NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA (“ADC” or the “Company”) (NYSE: ADCT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether ADC and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On June 3, 2026, ADC “announced topline data from its Phase 3 LOTIS-5 confirmatory trial evaluating ZYNLONTA® (loncastuximab tesirine-lpyl) in combination with rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma (r/r DLBCL).” Although ADC’s treatment extended progression-free survival by 1.4 months, 27 deaths were recorded for those given Zynlonta, compared to the nine deaths recorded for the immunotherapy arm.
On this news, ADC’s stock price fell $2.05 per share, or 66.56%, over the following two trading sessions, to close at $1.03 per share on June 5, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Planned ~17% workforce reduction expected to generate annualized estimated savings of approximately $10M, enhancing financial flexibility
Company focused on delivering upcoming regulatory and clinical milestones, including planned LOTIS-5 sBLA submission and full LOTIS-7 data by end of 2026
, /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced a strategic reorganization to focus resources behind key value-driving initiatives in support of the ZYNLONTA® (loncastuximab tesirine-lpyl) franchise.
As part of the reorganization, ADC Therapeutics plans to reduce its workforce globally by approximately 17 percent. The reduction is driven by the expected completion of the LOTIS-5 and LOTIS-7 trials this year, as well as operational efficiencies. With these changes, the Company is resourced to deliver on its key clinical, regulatory and manufacturing activities while maintaining the full externally facing medical affairs and commercial footprint to support ZYNLONTA.
"As we further assess the Phase 3 LOTIS-5 trial outcomes, including feedback from key medical experts, we continue to believe in the favorable overall benefit-risk profile and look forward to our pre-supplemental Biologics License Application (sBLA) meeting with the U.S. Food and Drug Administration in August," said Ameet Mallik, Chief Executive Officer of ADC Therapeutics. "This strategic reorganization will enable us to increase our financial flexibility as we prepare for upcoming LOTIS-5 regulatory milestones and continue building on the broader opportunity for ZYNLONTA through LOTIS-7 and support for the indolent lymphoma investigator-initiated trials (IITs). We are grateful to all of our employees for their efforts to help make a meaningful impact for patients and thank them for their important contributions to our company."
The Company is preparing for a scheduled pre-sBLA meeting with the FDA in August 2026 to discuss the potential regulatory path forward for ZYNLONTA in combination with rituximab to treat relapsed or refractory diffuse large B-cell lymphoma (r/r DLBCL) following the recent topline data results from the Phase 3 LOTIS-5 trial. ADC Therapeutics expects to submit an sBLA in the fourth quarter of 2026.
In addition, the Company continues to advance the ZYNLONTA franchise through the ongoing Phase 1b LOTIS-7 trial evaluating ZYNLONTA in combination with glofitamab in 2L+ DLBCL, with data anticipated by the end of 2026, as well as through support for Phase 2 IITs exploring ZYNLONTA across indolent lymphomas.
ADC Therapeutics expects the reorganization to generate annualized estimated cost savings of approximately $10 million. ADC Therapeutics estimates that it will incur one-time pre-tax charges of approximately $3 million for employee severance, benefits and related termination costs, the majority of which will be recognized in the second quarter of 2026. The Company has an expected cash runway at least into 2028.
About ZYNLONTA®
ZYNLONTA® is a CD19-directed antibody drug conjugate (ADC). Once bound to a CD19-expressing cell, ZYNLONTA is internalized by the cell, where enzymes release a pyrrolobenzodiazepine (PBD) payload. The potent payload binds to DNA minor groove with little distortion, remaining less visible to DNA repair mechanisms. This ultimately results in cell cycle arrest and tumor cell death.
The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved ZYNLONTA (loncastuximab tesirine-lpyl) for the treatment of adult patients with relapsed or refractory (r/r) large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified (NOS), DLBCL arising from low-grade lymphoma and also high-grade B-cell lymphoma. The trial included a broad spectrum of heavily pre-treated patients (median three prior lines of therapy) with difficult-to-treat disease, including patients who did not respond to first-line therapy, patients refractory to all prior lines of therapy, patients with double/triple hit genetics and patients who had stem cell transplant and CAR-T therapy prior to their treatment with ZYNLONTA. This indication is approved by the FDA under accelerated approval and in the European Union under conditional approval based on overall response rate and continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. Please see full prescribing information including important safety information about ZYNLONTA at www.ZYNLONTA.com.
ZYNLONTA is also being evaluated as a therapeutic option in combination studies in other B-cell malignancies and earlier lines of therapy.
About ADC Therapeutics
ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), transforming treatment for patients through our focused portfolio with ZYNLONTA® (loncastuximab tesirine-lpyl).
ADC Therapeutics' CD19-directed ADC ZYNLONTA received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. ZYNLONTA is also in development in combination with other agents and in earlier lines of therapy.
Headquartered in Lausanne (Biopôle), Switzerland, with operations in New Jersey, ADC Therapeutics is focused on driving innovation in ADC development with specialized capabilities from clinical to manufacturing and commercialization. Learn more at adctherapeutics.com and follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify forward-looking statements by terminology such as "may", "will", "should", "would", "expect", "intend", "plan", "anticipate", "believe", "estimate", "predict", "potential", "seem", "seek", "future", "continue", or "appear" or the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to: the cost and effects of the strategic restructuring and workforce reduction including our ability to achieve the estimated cost savings; the adequacy of the LOTIS-5 clinical trial data to support full regulatory approval and our ability to maintain accelerated approval in the United States and foreign jurisdictions for our product; the timing, content and outcome of meetings with and feedback or other communications provided by regulatory authorities including U.S. FDA; the timing, submission and acceptance of an sBLA submission related to LOTIS-5 and potential approval; the actual and perceived benefit-risk profile for ZYNLONTA as studied in the LOTIS-5 trial; the assessment of the data from LOTIS-5 study, including additional analyses of outcomes observed for safety, efficacy and within key geographic regions and across certain patient sub-populations; the path for full regulatory approval for ZYNLONTA in the United States and foreign jurisdictions; our ability to identify and execute value-maximizing options and the cost and impact of such options; our expected cash runway into at least 2028 assumes use of minimum liquidity amount required to be maintained under its loan agreement covenants; our ability to comply with the terms of our indebtedness; changes in our regulatory and commercial strategy; the Company's ability to sustain or grow ZYNLONTA® revenue in the United States and potential peak revenue; the ability of our partners to commercialize ZYNLONTA® in foreign markets, the timing and amount of future revenue and payments to us from such partnerships and their ability to obtain regulatory approval for ZYNLONTA® in foreign jurisdictions; the timing, results and publication of the Company's clinical trials including LOTIS-7; the timing, publication and results of investigator-initiated trials including those studying FL and MZL and the potential regulatory and/or compendia strategy and the future opportunity; the timing and outcome of regulatory submissions for the Company's products or product candidates; actions by the FDA or foreign regulatory authorities; projected revenue and expenses; the Company's indebtedness, including HealthCare Royalty Management and Blue Owl and Oaktree facilities, and the restrictions imposed on the Company's activities by such indebtedness, the ability to comply with the terms of the various agreements and repay such indebtedness and the significant cash required to service such indebtedness; and the Company's ability to obtain financial and other resources for its research, development, clinical, and commercial activities; and the uncertainties of international trade policies, including tariffs, sanctions, trade barriers and most favored nation drug pricing and the potential impact they may have on our business, financial condition, and results of operations. Additional information concerning these and other factors that may cause actual results to differ materially from those anticipated in the forward-looking statements is contained in the "Risk Factors" section of the Company's Annual Report on Form 10-K and in the Company's other periodic and current reports and filings with the U.S. Securities and Exchange Commission. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, achievements or prospects to be materially different from any future results, performance, achievements or prospects expressed in or implied by such forward-looking statements. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document.
CONTACTS:
Investors and Media
Nicole Riley
ADC Therapeutics
[email protected]
+1 862-926-9040
, /PRNewswire/ -- NNN REIT, Inc. (NYSE: NNN) ("NNN" or the "Company"), a real estate investment trust ("REIT"), today announced the exercise of its $200 million incremental term loan option under its senior unsecured term loan facility, increasing the aggregate facility size to $500 million (the "Term Loan"). The incremental borrowings carry identical terms to the existing $300 million term loan (after giving effect to the amendments described below). The Term Loan matures on February 15, 2029, with two one-year extension options. NNN expects to use proceeds from the incremental term loan for general corporate purposes.
In anticipation of the incremental term loan, NNN entered into a $100 million forward starting swap that fixes SOFR at 3.43% through February 15, 2029.
"We are pleased with today's transactions, which enhance our financial flexibility, provide capital to fund our business plans, and lower our cost of capital," said Vincent H. Chao, Chief Financial Officer. "We greatly appreciate the continued support and long-standing relationships with our bank group."
Additionally, the Company amended the pricing grids on the Term Loan and its existing senior unsecured revolving credit facility, (the "Revolving Credit Facility"). Based on NNN's current credit ratings, the applicable SOFR-based margin was lowered to 0.800% from 0.850% for all outstanding Term Loan borrowings and 0.725% from 0.775% for all Revolving Credit Facility borrowings.
Wells Fargo Securities, LLC and BofA Securities, Inc., served as the Joint Lead Arrangers and Joint Bookrunners, with Wells Fargo Bank, National Association acting as the Administrative Agent and Bank of America, N.A. acting as the Syndication Agent.
Truist Securities, Inc., PNC Capital Markets LLC, U.S. Bank National Association, Royal Bank of Canada and TD Bank, N.A., served as Joint Lead Arrangers, with Truist Bank, PNC Bank, National Association, U.S. Bank National Association, Royal Bank of Canada, TD Bank, N.A., and Mizuho Bank Ltd., acting as Documentation Agents. Sumitomo Mitsui Banking Corporation, New York Branch, and Raymond James Bank also participated in the transaction.
About NNN REIT, Inc.
NNN is a REIT that invests in high-quality properties subject generally to long-term, net leases with minimal ongoing capital expenditures. As of March 31, 2026, the Company owned 3,711 properties across all 50 states, the District of Columbia and Puerto Rico, encompassing approximately 39.6 million square feet of gross leasable area, with a weighted average remaining lease term of 10.1 years. For additional information, please visit www.nnnreit.com.
Crocs (CROX - Free Report) closed at $121.14 in the latest trading session, marking a -2.15% move from the prior day. This change lagged the S&P 500's daily loss of 1.44%. Meanwhile, the Dow experienced a drop of 0.09%, and the technology-dominated Nasdaq saw a decrease of 2.22%.
The footwear company's stock has climbed by 12.1% in the past month, exceeding the Consumer Discretionary sector's loss of 1.97% and the S&P 500's gain of 0.08%.
The investment community will be closely monitoring the performance of Crocs in its forthcoming earnings report. On that day, Crocs is projected to report earnings of $4.3 per share, which would represent year-over-year growth of 1.65%. In the meantime, our current consensus estimate forecasts the revenue to be $1.15 billion, indicating a 0.1% decline compared to the corresponding quarter of the prior year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $13.67 per share and revenue of $4.08 billion. These totals would mark changes of +9.27% and +0.97%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Crocs. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.02% lower within the past month. Crocs currently has a Zacks Rank of #3 (Hold).
Investors should also note Crocs's current valuation metrics, including its Forward P/E ratio of 9.06. This signifies a discount in comparison to the average Forward P/E of 15.4 for its industry.
Investors should also note that CROX has a PEG ratio of 1.28 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. Textile - Apparel stocks are, on average, holding a PEG ratio of 2.01 based on yesterday's closing prices.
The Textile - Apparel industry is part of the Consumer Discretionary sector. This group has a Zacks Industry Rank of 156, putting it in the bottom 37% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
On June 24, 2026, we present a DCF analysis for Northrop Grumman Corp NOC , a company currently facing a challenging price performance context with a year-to-date decline of 9.3% and a one-month drop of 7.2%. Below are key highlights from our analysis:
DCF Earnings-based intrinsic value of $435.16 compared to the current price of $513.22 (margin of safety: -17.9%) DCF Free Cash Flow (FCF)-based intrinsic value of $290.99, indicating a second opinion on valuation GF Score™ of 86/100, suggesting a high reliability of the DCF inputs What Is NOC Worth? DCF Earnings-Based Model The DCF earnings-based model for Northrop Grumman Corp utilizes a two-stage approach to estimate intrinsic value. In the first stage, we project earnings growth over the next ten years at a rate of 8.2%, followed by a terminal growth phase at a reduced rate of 4% for the subsequent ten years. The discount rate applied is 11%, derived from the risk-free rate and equity risk premium.
Parameter Value Current EPS (TTM, excl. non-recurring) $30.60 10-Year Growth Rate 8.2% 10-Year Treasury Rate 4.49% Discount Rate (ceil(Treasury) + 6%) 11% Terminal Growth Rate 4% The calculation summary for the two-stage DCF model is as follows:
Stage Description Value Growth Stage (Years 1-10) EPS growing at 8.2%, discounted at 11% $266.60 Terminal Stage (Years 11-20) 4% terminal growth, discounted at 11% $168.56 Intrinsic Value Growth + Terminal $435.16 With the current price at $513.22, the intrinsic value of $435.16 indicates that Northrop Grumman is fairly valued, with a margin of safety of -17.9%. It is important to note that GuruFocus uses EPS excluding non-recurring items, as research suggests that stock prices correlate more closely with earnings than with free cash flow. For further details, visit the NOC DCF Calculator.
What Does the Free Cash Flow DCF Say? The Free Cash Flow (FCF)-based intrinsic value for Northrop Grumman stands at $290.99. When comparing this to the earnings-based intrinsic value of $435.16, the two models diverge significantly. The FCF model suggests that the stock is modestly overvalued, with a margin of safety of -76.4%.
How Does GF Value™ Compare to the DCF Models? The GF Value™ for Northrop Grumman is calculated at $557.59, providing a third perspective on valuation. GF Value™ is GuruFocus' proprietary measure, which considers historical trading multiples, past business growth, and future performance estimates. While the DCF earnings model suggests fair valuation, the FCF model indicates overvaluation, whereas GF Value™ suggests the stock is undervalued. This divergence highlights the importance of considering multiple valuation methods. For more information, visit the GF Value™ page.
What Does NOC's GF Score™ Tell Us? The GF Score™ ranks stocks from 0 to 100 based on five key aspects: Financial Strength, Profitability, Growth, Valuation, and Momentum. Stocks with higher GF Score™ values have been found to generate higher long-term returns based on backtested data from 2006 to 2021.
Metric Rating GF Score™ 86/100 Financial Strength 6/10 Profitability 8/10 Growth 7/10 Valuation 10/10 Momentum 7/10 With a predictability rank of 0/5 stars, it is important to note that higher predictability ratings typically indicate that the DCF model is more reliable for the stock. For further insights, visit the NOC stock page.
Key Assumptions and Limitations It is crucial to recognize that DCF models are highly sensitive to growth rate and discount rate assumptions. Stocks with low predictability ratings, such as Northrop Grumman, tend to produce less reliable DCF estimates. Additionally, the terminal growth rate of 4% is a simplifying assumption that may not reflect future market conditions accurately.
What This Means for Investors In synthesizing the three valuation models—DCF earnings, DCF FCF, and GF Value™—we find that Northrop Grumman Corp presents a mixed picture. While the DCF earnings model suggests fair valuation, the FCF model indicates modest overvaluation, and the GF Value™ suggests it is undervalued. Overall, the consensus leans towards the stock being fairly valued.
For the full DCF analysis, visit the NOC DCF Calculator. You can also explore the GF Value™ page, or use the GuruFocus Stock Screener to find undervalued predictable companies.
Frequently Asked Questions What is NOC's intrinsic value based on DCF?
According to our analysis, the earnings-based intrinsic value is $435.16, while the FCF-based intrinsic value is $290.99.
Is NOC overvalued or undervalued?
The DCF earnings model suggests fair valuation, while the FCF model indicates modest overvaluation. The GF Value™ suggests it is undervalued, creating a mixed consensus.
How reliable is the DCF model for NOC?
Given the predictability rank of 0/5, the DCF model for NOC may be less reliable compared to stocks with higher predictability ratings.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
ZEELAND, Mich. and STEINHAGEN, Germany, June 24, 2026 (GLOBE NEWSWIRE) -- Gentex Corporation and Hörmann today announced a strategic agreement to integrate Hörmann’s connected garage door opener technology into HomeLink, the automotive industry’s leading car-to-home automation system.
The partnership will enable Gentex customers across Europe to control compatible Hörmann garage door systems via HomeLink, securely triggering garage door open/close commands from the HomeLink app or directly from a connected vehicle through the HomeLink cloud.
HomeLink is the automotive industry’s most trusted and comprehensive car-to-home automation system. The latest version utilizes radio frequency, Long-Range Bluetooth®, and cloud-based technologies to activate garage doors, gates, lights, and other smart home devices directly from the vehicle. HomeLink is available on nearly 300 vehicle models from over 50 automaker brands, with approximately 110 million units currently in operation worldwide.
Hörmann, Europe’s leading provider of gates, doors, door frames, operators, access control systems, and storage solutions, offers a wide range of connected operator solutions that allow users to conveniently monitor and control their access points via smartphone apps. Through this integration, Hörmann customers will gain seamless in-vehicle control and expanded remote access capabilities via the HomeLink ecosystem.
“This partnership represents an important step in expanding connected vehicle-to-home experiences across Europe,” said Thorsten Lünstroth, Head of Product Management at Hörmann. “By integrating with HomeLink, we are enabling our customers to enjoy more convenient, secure, and intelligent access to their homes directly from their vehicles.”
“It’s exciting to expand HomeLink’s cloud-based garage door control capabilities through our partnership with Hörmann,” said Neil Boehm, chief technology officer and chief operating officer at Gentex. “Hörmann is a highly respected brand in the European access solutions market, and this collaboration strengthens HomeLink’s position as the most versatile and comprehensive car-to-home automation system — capable of supporting leading smart home technologies around the world.”
The integration will support remote monitoring, secure activation, and enhanced user convenience, while maintaining the reliability and performance expected from both companies’ technologies. This collaboration further advances Gentex’s strategy to expand HomeLink’s global ecosystem through partnerships with leading smart home and access control providers.
About Hörmann
The Hörmann Group is Europe’s leading manufacturer of gates and doors. At over 40 highly specialized plants in Europe, North America, and Asia, more than 6,000 employees develop and manufacture high-quality gates, doors, frames, operators, access control systems, and storage solutions for use in residential and commercial properties.
The global Hörmann Group is headquartered in the East Westphalian town of Steinhagen near Bielefeld. The family-run company most recently reported annual revenue of more than 1 billion euros. For more information, visit www.hoermann.com.
About Gentex
Founded in 1974, Gentex Corporation (NASDAQ: GNTX) is a technology company that leverages its core competencies, strategic partnerships, acquisitions, and ongoing research to create market-leading positions in a variety of verticals. You can view some of the Company’s latest technology at www.gentex.com.
Gentex Media Contact
Craig Piersma
(616) 772-1590 x4316 [email protected]
Investors with an interest in Computers - IT Services stocks have likely encountered both TD SYNNEX (SNX) and Dynatrace (DT). But which of these two companies is the best option for those looking for undervalued stocks?
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Coursera, Inc. (NYSE: COUR), a leading global online learning platform, has posted materials for today’s supplemental post-merger modeling call to its investor relations website at investor.coursera.com.
Conference Call Details
As previously announced, Coursera will hold a conference call where the company’s chief financial officer, Mike Foley, will provide an overview of the combined company’s full year 2026 financial profile following the close of its merger with Udemy, Inc. on May 11, 2026. Prepared remarks will be followed by an analyst question-and-answer session today, June 23, 2026, at 5:30 a.m. Pacific Time (8:30 a.m. Eastern Time).
A live, audio-only webcast of the conference call and supplemental materials can be found on our investor relations page at investor.coursera.com. For those unable to listen to the broadcast live, an archived replay will be accessible in the same location for one year.
Disclosure Information
In compliance with disclosure obligations under Regulation FD, Coursera announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission (“SEC”), press releases, company blog posts, public conference calls, and webcasts, as well as via Coursera’s investor relations website.
About Coursera
Coursera was launched in 2012 by Andrew Ng and Daphne Koller with a mission to provide universal access to world-class learning. Coursera partners with leading university and industry partners to offer a broad catalog of content and credentials, including courses, Specializations, Professional Certificates, and degrees. Coursera’s platform innovations — including AI-powered personalized guide and features, like Role Play and Course Builder, and role-based solutions like Skills Tracks — enable instructors, partners, and companies to deliver scalable, personalized, and verified learning. Institutions worldwide rely on Coursera to upskill and reskill their employees, students, and citizens in high-demand fields such as GenAI, data science, technology, and business, while learners globally turn to Coursera to master the skills they need to advance their careers. Coursera is a Delaware public benefit corporation and a B Corp. Coursera recently combined with Udemy to create one of the world’s most comprehensive skills development platforms.
Coursera, Inc. (NYSE: COUR), a leading global online learning platform, has posted materials for today’s supplemental post-merger modeling call to its investor relations website at investor.coursera.com.
Conference Call Details
As previously announced, Coursera will hold a conference call where the company’s chief financial officer, Mike Foley, will provide an overview of the combined company’s full year 2026 financial profile following the close of its merger with Udemy, Inc. on May 11, 2026. Prepared remarks will be followed by an analyst question-and-answer session today, June 23, 2026, at 5:30 a.m. Pacific Time (8:30 a.m. Eastern Time).
A live, audio-only webcast of the conference call and supplemental materials can be found on our investor relations page at investor.coursera.com. For those unable to listen to the broadcast live, an archived replay will be accessible in the same location for one year.
Disclosure Information
In compliance with disclosure obligations under Regulation FD, Coursera announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission (“SEC”), press releases, company blog posts, public conference calls, and webcasts, as well as via Coursera’s investor relations website.
About Coursera
Coursera was launched in 2012 by Andrew Ng and Daphne Koller with a mission to provide universal access to world-class learning. Coursera partners with leading university and industry partners to offer a broad catalog of content and credentials, including courses, Specializations, Professional Certificates, and degrees. Coursera’s platform innovations — including AI-powered personalized guide and features, like Role Play and Course Builder, and role-based solutions like Skills Tracks — enable instructors, partners, and companies to deliver scalable, personalized, and verified learning. Institutions worldwide rely on Coursera to upskill and reskill their employees, students, and citizens in high-demand fields such as GenAI, data science, technology, and business, while learners globally turn to Coursera to master the skills they need to advance their careers. Coursera is a Delaware public benefit corporation and a B Corp. Coursera recently combined with Udemy to create one of the world’s most comprehensive skills development platforms.
Source Code: COUR-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20260623736875/en/
Here are three stocks with buy rank and strong value characteristics for investors to consider today, June 24:
Navigator Holdings Ltd. (NVGS - Free Report) : This global operator of a fleet of liquefied gas carriers carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 29.5% over the last 60 days.
Navigator has a price-to-earnings ratio (P/E) of 10.84, compared with 22.97 for the S&P 500. The company possesses a Value Score of B.
Byline Bancorp, Inc. (BY - Free Report) : This bank holding company for Byline Bank carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.2% over the last 60 days.
Byline has a price-to-earnings ratio (P/E) of 10.82, compared with 22.97 for the S&P 500. The company possesses a Value Score of B.
Neurocrine Biosciences, Inc. (NBIX - Free Report) : This developer of innovative therapies for neurological and endocrine disorders carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.4% over the last 60 days.
Neurocrine has a price-to-earnings ratio (P/E) of 17.67, compared with 22.97 for the S&P 500. The company possesses a Value Score of B.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Learn more about the Value score and how it is calculated here.
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Byline Bancorp, Inc. (BY - Free Report) : This bank holding company for Byline Bank has seen the Zacks Consensus Estimate for its current year earnings increasing 6.2% over the last 60 days.
Navigator Holdings Ltd. (NVGS - Free Report) : This global operator of a fleet of liquefied gas carriers has seen the Zacks Consensus Estimate for its current year earnings increasing 29.5% over the last 60 days.
Neurocrine Biosciences, Inc. (NBIX - Free Report) : This developer of innovative therapies for neurological and endocrine disorders has seen the Zacks Consensus Estimate for its current year earnings increasing 14.4% over the last 60 days.
TFI International Inc. (TFII - Free Report) : This transportation and logistics company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.6% over the last 60 days.
Bunge Global SA (BG - Free Report) : This agricultural and food company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.3% over the last 60 days.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Paccar (PCAR - Free Report) ended the recent trading session at $116.78, demonstrating a -2.78% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1.44%. Meanwhile, the Dow lost 0.09%, and the Nasdaq, a tech-heavy index, lost 2.22%.
The truck maker's stock has climbed by 9.85% in the past month, exceeding the Auto-Tires-Trucks sector's loss of 3.79% and the S&P 500's gain of 0.08%.
Analysts and investors alike will be keeping a close eye on the performance of Paccar in its upcoming earnings disclosure. The company's upcoming EPS is projected at $1.32, signifying a 3.65% drop compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $7.1 billion, reflecting a 1.92% rise from the equivalent quarter last year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $5.59 per share and a revenue of $27.7 billion, indicating changes of +11.58% and +5.59%, respectively, from the former year.
Investors should also note any recent changes to analyst estimates for Paccar. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Paccar is holding a Zacks Rank of #3 (Hold) right now.
Looking at valuation, Paccar is presently trading at a Forward P/E ratio of 21.5. This signifies a premium in comparison to the average Forward P/E of 20.13 for its industry.
Meanwhile, PCAR's PEG ratio is currently 1.12. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. By the end of yesterday's trading, the Automotive - Domestic industry had an average PEG ratio of 0.99.
The Automotive - Domestic industry is part of the Auto-Tires-Trucks sector. This group has a Zacks Industry Rank of 104, putting it in the top 43% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
, /PRNewswire/ - Wheaton Precious Metals™ Corp. ("Wheaton" or the "Company") is pleased to announce that it has again been named to Corporate Knights' 2026 Best 50 Corporate Citizens in Canada (the "Best 50"), ranking 13th overall.
"We are proud to once again be recognized by Corporate Knights as one of Canada's best corporate citizens," said Haytham Hodaly, President and Chief Executive Officer of Wheaton. "This consistent recognition reflects our commitment to disciplined capital allocation and partnering with mine operators who prioritize responsible business practices."
The Best 50 is one of Canada's most established sustainability benchmarks, assessing more than 350 large companies using a transparent, data-driven methodology focused on the share and growth of revenues tied to sustainable activities. Wheaton's inclusion reflects the quality of its portfolio, its strong organic growth profile, and its approach to partnering with leading operators, underpinned by a broader commitment to conducting business responsibly and sustainably.
Earlier this year, Wheaton was also recognized among Corporate Knights' 2026 global 100 most sustainable corporations in the world.
To learn more about Wheaton's sustainability approach and commitments, please visit: www.wheatonpm.com/Sustainability.
About Wheaton Precious Metals Corp.
Wheaton Precious Metals is the world's premier precious metals streaming company, providing shareholders with access to a high-quality portfolio of low-cost, long-life mines around the world. Through strategic streaming agreements, Wheaton partners with mining companies to secure a portion of their future precious metals production. Committed to responsible mining practices, Wheaton employs due diligence practices with a goal of unlocking long-term value for shareholders while supporting the broader mining industry to deliver the commodities society needs through access to capital. Wheaton's shares are listed on the Toronto Stock Exchange, New York Stock Exchange and London Stock Exchange under the symbol WPM.
Cautionary Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of applicable Canadian securities legislation concerning the business, operations and financial performance of Wheaton. Forward-looking statements, which are all statements other than statements of historical fact, include, but are not limited to, statements with respect to innovative mining technology, the potential success of that technology, and its ability to be commercialized, ESG and climate change strategy, targets and commitments and climate scenario analysis by Wheaton and at mineral stream interests currently owned by Wheaton (the "Mining Operations"). Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Wheaton to be materially different from those expressed or implied by such forward-looking statements including (without limitation) risks related to the ability to identify innovative mining technology, the potential success of that technology and the ability to commercialize that technology, risks related to the ability to achieve ESG and climate change strategy, targets and commitments at both Wheaton and the Mining Operations and other risks discussed in the section entitled "Description of the Business – Risk Factors" in Wheaton's Annual Information Form for the year ended December 31, 2025 and the risks identified under "Risks and Uncertainties" in Wheaton's Management's Discussion and Analysis ("MD&A") for the year ended December 31, 2025, both available on SEDAR+ and in Wheaton's Form 6-K filed March 12, 2026, all available on EDGAR (the "Disclosure"). Forward-looking statements are based on assumptions management currently believes to be reasonable, including (without limitation) that Wheaton will be able to identify innovative mining technology, ESG and climate change strategy, targets and commitments at both Wheaton and the Mining Operations will be achieved, there will be no material adverse change in the market price of commodities, that estimations of future production from the Mining Operations and mineral reserves and resources are accurate, that the mining operations from which Wheaton purchases precious metals will continue to operate, that each party will satisfy their obligations in accordance with the precious metals purchase agreements, and such other assumptions and factors as set out in the Disclosure
Key Takeaways IBKR added ChatGPT and Grok, extending AI-assisted trading to options and futures.IBKR clients can link accounts to ChatGPT, Grok or Claude without passwords or API keys.IBKR requires review and approval of every AI instruction before orders reach markets. Interactive Brokers (IBKR - Free Report) is further accelerating its push into artificial intelligence (AI) by adding ChatGPT and Grok to its expanding suite of AI-enabled investing solutions. The enhancement will expand AI-assisted trading beyond stocks and exchange-traded funds (ETFs) to include options, futures and futures options, enabling investors to interact with a broader range of markets through conversational prompts.
The launch builds on IBKR's earlier integration with Anthropic's Claude and highlights the broker's efforts to simplify market analysis and trading workflows without compromising investor oversight.
Now, existing customers can connect their IBKR accounts to ChatGPT, Grok or Claude within minutes at no additional cost, using their standard IBKR credentials and without sharing passwords or API keys with third-party providers.
As interest in AI-powered investing gains momentum, IBKR is positioning itself at the forefront of this shift. Users can leverage AI assistants to assess portfolio exposures, explore hedging strategies, track technical indicators such as the relative strength index, benchmark performance against major ETFs and create futures order instructions.
However, execution remains firmly in investors’ hands, as every AI-generated instruction must be reviewed and approved through a dedicated AI Instructions tab before reaching the market.
How IBKR Builds on AI & Platform InvestmentsThe latest AI integrations complement an expanding suite of tools already available across Interactive Brokers' platforms. AI Screeners allow investors to search more than 70,000 global stocks using conversational prompts, while Investment Themes help users explore opportunities tied to trends, such as clean energy and cloud computing.
IBKR also introduced Connections, which maps relationships among companies, ETFs, derivatives and thematic datasets from a single interface. Ask IBKR enables clients to query portfolio exposure and concentration in plain language, and AI News Summaries provide concise updates tailored to holdings and watch lists.
Beyond AI, Interactive Brokers recently launched a unified interface for prediction-market contracts offered through Kalshi, CME and ForecastEx. The company has also added stablecoin funding capabilities, expanded access to Coinbase Derivatives products and benefited from growing engagement, with overnight trading volumes climbing to 8.1 million trades in the first quarter of 2026 from 2.8 million a year earlier.
For IBKR, these investments are part of a long-term strategy to simplify investing while broadening access to institutional-grade capabilities. By steadily adding new asset classes, intelligent research tools and innovative trading workflows, the company aims to help investors make better-informed decisions while ensuring that final control over every transaction remains in the hands of clients.
IBKR’s Price Performance & Zacks RankIn the last six months, Interactive Brokers shares have gained 46.7%, outperforming the industry’s 4.1% growth.
Image Source: Zacks Investment Research
Currently, the company carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
IBKR’s Competitive LandscapeInteractive Brokers is not alone in embedding AI into investing workflows. Several brokerages and investment platforms have accelerated their AI initiatives over the past year, though their approaches differ.
Among retail brokers, Robinhood Markets, Inc. (HOOD - Free Report) launched AI-enabled trading accounts that allow users to connect AI agents, including Claude and ChatGPT-based tools, to analyze portfolios and execute stock trades within predefined limits. Robinhood is also extending AI capabilities to credit-card purchases through agent-driven workflows.
Charles Schwab (SCHW - Free Report) incorporated an AI assistant into its platform, with a focus on helping investors navigate research, educational content and trading tools. Rather than emphasizing autonomous trading, Schwab's approach centers on improving investor support and platform usability.
Interactive Brokers Group, Inc. (IBKR - Free Report) closed at $94.70 in the latest trading session, marking a -2.19% move from the prior day. This change lagged the S&P 500's 1.44% loss on the day. Meanwhile, the Dow lost 0.09%, and the Nasdaq, a tech-heavy index, lost 2.22%.
The company's shares have seen an increase of 19.02% over the last month, surpassing the Finance sector's gain of 3.16% and the S&P 500's gain of 0.08%.
The upcoming earnings release of Interactive Brokers Group, Inc. will be of great interest to investors. The company is expected to report EPS of $0.59, up 15.69% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $1.66 billion, indicating a 12.16% increase compared to the same quarter of the previous year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $2.46 per share and a revenue of $6.9 billion, signifying shifts of +12.33% and +12.14%, respectively, from the last year.
Investors might also notice recent changes to analyst estimates for Interactive Brokers Group, Inc. These revisions help to show the ever-changing nature of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. As of now, Interactive Brokers Group, Inc. holds a Zacks Rank of #3 (Hold).
In terms of valuation, Interactive Brokers Group, Inc. is currently trading at a Forward P/E ratio of 39.41. Its industry sports an average Forward P/E of 14.63, so one might conclude that Interactive Brokers Group, Inc. is trading at a premium comparatively.
We can additionally observe that IBKR currently boasts a PEG ratio of 2.68. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As the market closed yesterday, the Financial - Investment Bank industry was having an average PEG ratio of 1.09.
The Financial - Investment Bank industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 104, placing it within the top 43% of over 250 industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
, /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WIMI" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, has completed systematic benchmark testing on fully parameterized quantum convolutional neural networks. Its research team has proposed a quantum neural network model inspired by classical convolutional neural networks. Throughout the entire computational process, this model only adopts two-qubit interactions. It not only retains the simplicity of the network architecture but also greatly lowers the implementation difficulty of quantum circuits, laying a crucial foundation for its practical deployment on noisy intermediate-scale quantum computers in the future.
Unlike traditional deep learning networks, classical convolutional neural networks generally rely on massive parameters and sophisticated hierarchical structures to perform feature extraction. For instance, in image classification tasks, convolutional layers continuously scan input images to extract local features, after which pooling layers compress feature dimensions, and fully connected layers ultimately generate classification decisions. Although this architecture has achieved remarkable success, the training and inference costs surge exponentially as model scales keep expanding.
The research team at WIMI holds that quantum computing is inherently capable of processing high-dimensional feature spaces. A quantum system consisting of n qubits can represent a 2ⁿ-dimensional state space simultaneously, which enables it to tackle complex pattern recognition tasks with far fewer parameters than classical algorithms. This potential advantage has driven the research team to rethink the implementation of convolutional neural networks and attempt to build convolutional quantum neural network architectures via quantum gate operations.
To this end, WIMI has designed a fully parameterized Quantum Convolutional Neural Network (QCNN) architecture. The network mainly comprises a quantum data encoding layer, a quantum convolutional layer, a quantum pooling layer, a feature compression layer and a quantum classification layer. Distinct from many complex quantum networks built on multi-qubit gate operations, this model takes two-qubit interactions as its basic computational unit, which effectively controls circuit depth and mitigates noise accumulation.
In the data input phase, raw classical images first go through preprocessing modules for dimensionality reduction and normalization. Given the limited number of qubits supported by current quantum hardware, researchers need to map high-dimensional image data onto a finite qubit space. To address this challenge, WIMI has investigated multiple classical data preprocessing strategies including principal component analysis, feature selection and image compression techniques, ensuring the input data adapts to quantum computing resource constraints while preserving core information.
Once preprocessing finishes, data proceeds to the quantum encoding stage. As a cornerstone of quantum machine learning, quantum encoding converts classical data into quantum state representations. WIMI has systematically compared a range of quantum encoding schemes such as angle encoding, amplitude encoding and hybrid encoding methods. Experimental results reveal that different encoding strategies directly determine the network's representation capacity and training efficiency. Angle encoding leverages rotation gates to map data into the parameter space of quantum states, featuring straightforward implementation and strong noise robustness. By contrast, amplitude encoding can express higher-dimensional data with fewer qubits yet comes with relatively higher implementation complexity.
After data is encoded into quantum states, the network executes quantum convolution operations. Classical convolutional neural networks extract features by sliding convolutional kernels over local regions, while QCNN implements convolution via parameterized two-qubit gates. WIMI has constructed a series of trainable quantum gate arrays that establish correlations between different features through quantum entanglement. Since quantum states can exist as superpositions of multiple states concurrently, the network can process numerous potential feature combinations in parallel within a single computation, delivering more efficient feature extraction than classical convolution methods.
Notably, the model follows a fully parameterized design principle. While certain quantum gate parameters are often fixed in conventional quantum neural networks, the architecture proposed by WIMI allows all key quantum gate parameters to be updated during training. This design substantially boosts the model's expressive power, enabling it to learn intricate data distribution patterns.
Following quantum convolution, the network enters the quantum pooling stage. Classical pooling layers reduce feature dimensions through max pooling or average pooling, whereas quantum pooling screens valid information via measurement, entanglement reconstruction and quantum state compression. By gradually cutting down the number of qubits involved in computation, the network reduces subsequent computational complexity while retaining critical feature information.
From an information processing perspective, this mechanism mirrors the feature abstraction process in classical deep learning. As network layers deepen, low-level features including edges, textures and shapes in input images are progressively converted into high-level semantic abstract representations, supporting the final classification task.
WIMI has tested multiple QCNN configurations covering diverse parameterized quantum circuit architectures, data encoding schemes, loss functions and optimization algorithm combinations. Experimental results demonstrate that QCNN achieves outstanding classification performance across most test scenarios. Most importantly, even with far fewer parameters than classical convolutional neural networks, QCNN matches or even exceeds the classification accuracy of traditional CNNs. This outcome proves that quantum neural networks deliver higher parameter utilization efficiency; in other words, quantum models can learn richer data features with fewer trainable parameters and thus achieve superior overall performance.
Further analysis by WIMI attributes this competitive edge to the high-dimensional feature representation capability enabled by quantum entanglement. In classical neural networks, information exchange between neurons is constrained by connection topology, yet quantum entanglement builds non-classical correlations among multiple qubits, empowering the network with stronger representation capacity under limited computing resources. To enhance training stability, the research team has thoroughly explored optimization workflows. Training quantum neural networks frequently suffers from vanishing gradients and flat parameter regions, an issue known as the barren plateau phenomenon. To resolve this problem, the team evaluated various optimizers including stochastic gradient descent, Adam optimizer and quantum-specific optimization algorithms, and analyzed how different cost functions affect model training.
Experimental results verify that well-designed parameter initialization strategies and optimization pipelines can effectively ease training difficulties, allowing the network to converge stably within fewer training epochs. This research delivers valuable practical experience for training large-scale quantum neural networks in the future.
It is foreseeable that with the continuous advancement of quantum computing technologies, quantum convolutional neural networks will evolve into a core component of next-generation intelligent computing. From current classical data classification experiments to large-scale artificial intelligence applications in complex future scenarios, QCNN exhibits enormous potential to reshape the evolution of machine learning. WIMI's research not only advances the theoretical development of quantum machine learning but also pioneers innovative technical routes for developing efficient, low-parameter and high-performance new artificial intelligence systems, laying a solid foundation for the advent of the quantum intelligence era.
About WiMi Hologram Cloud
WiMi Hologram Cloud Inc. (NASDAQ: WiMi) focuses on holographic cloud services, primarily concentrating on professional fields such as in-vehicle AR holographic HUD, 3D holographic pulse LiDAR, head-mounted light field holographic devices, holographic semiconductors, holographic cloud software, holographic car navigation, metaverse holographic AR/VR devices, and metaverse holographic cloud software. It covers multiple aspects of holographic AR technologies, including in-vehicle holographic AR technology, 3D holographic pulse LiDAR technology, holographic vision semiconductor technology, holographic software development, holographic AR virtual advertising technology, holographic AR virtual entertainment technology, holographic ARSDK payment, interactive holographic virtual communication, metaverse holographic AR technology, and metaverse virtual cloud services. WiMi is a comprehensive holographic cloud technology solution provider. For more information, please visit http://ir.wimiar.com.
Translation Disclaimer
The original version of this announcement is the officially authorized and only legally binding version. If there are any inconsistencies or differences in meaning between the Chinese translation and the original version, the original version shall prevail. WiMi Hologram Cloud Inc. and related institutions and individuals make no guarantees regarding the translated version and assume no responsibility for any direct or indirect losses caused by translation inaccuracies.
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that measures a dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.
Zions (ZION - Free Report) is headquartered in Salt Lake City, and is in the Finance sector. The stock has seen a price change of 14.66% since the start of the year. The financial holding company is paying out a dividend of $0.45 per share at the moment, with a dividend yield of 2.68% compared to the Banks - West industry's yield of 2.57% and the S&P 500's yield of 1.44%.
Looking at dividend growth, the company's current annualized dividend of $1.80 is up 2.3% from last year. Over the last 5 years, Zions has increased its dividend 3 times on a year-over-year basis for an average annual increase of 5.20%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Zions's current payout ratio is 28%, meaning it paid out 28% of its trailing 12-month EPS as dividend.
Looking at this fiscal year, ZION expects solid earnings growth. The Zacks Consensus Estimate for 2026 is $6.44 per share, with earnings expected to increase 5.23% from the year ago period.
From greatly improving stock investing profits and reducing overall portfolio risk to providing tax advantages, investors like dividends for a variety of different reasons. It's important to keep in mind that not all companies provide a quarterly payout.
High-growth firms or tech start-ups, for example, rarely provide their shareholders a dividend, while larger, more established companies that have more secure profits are often seen as the best dividend options. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, ZION is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of #3 (Hold).
New research shows 80% of parents wish they had taken more family vacations with their children
ORLANDO, Fla.--(BUSINESS WIRE)--Club Wyndham®, the nation’s largest vacation club built around comfort, connection and together time, today launched 17 Summers, a new campaign inspired by a simple but powerful truth: the moments we share today become the memories we cherish for a lifetime.
Built around the concept that parents have 17 summers with their children before adulthood begins, the campaign encourages families to slow down, reconnect and make the most of the seasons that shape family stories. As a cornerstone vacation club brand of Travel + Leisure Co., Club Wyndham created 17 Summers to celebrate the moments that stay with us long after summer ends.
The campaign is supported by new data from a survey conducted by Talker Research for Club Wyndham, which found that:
91% of parents say time seems to move faster as their children get older, with 66% saying a single year can feel like two. 79% say they have limited time left to travel with their family before their children grow out of family vacations. 80% wish they had taken more vacations with their kids when they were younger. 90% say family travel is one of the best ways to build lasting memories. The findings underscore a growing desire among Americans to be more intentional about how they spend their time together as schedules become increasingly busy and childhood seems to pass more quickly.
"Vacation memories have a way of becoming part of your life story," said Annie Roberts, senior vice president of Club and Owner Services at Travel + Leisure Co. "As a mom, I've experienced firsthand how quickly childhood moves from one season to the next. The inspiration behind 17 Summers is simple: to remind people that the moments they'll cherish the most years from now are often the ones they're living right now. Years later, it’s rarely the itinerary you remember—it's the laughter, the traditions and the time spent with the people who matter most. Vacation creates space for those moments, and we want to help people make the most of them."
As part of the campaign, Club Wyndham will invite families to share their own 17 Summers stories through user-generated content, social media activations and digital experiences celebrating the traditions, adventures and small moments that make summer memorable.
The campaign will also feature storytelling content that reflects the evolving nature of family vacations—from young children discovering their first beach vacation to teenagers planning adventures with friends and creating new traditions together.
Make This Summer Count
To help families make the most of the time they have together, Club Wyndham is pairing the campaign with a special vacation offer designed to inspire one more getaway before summer fades into memory.
Now through Sept. 22, travelers can save 17% on rental stays at participating Club Wyndham properties by using promo code 17SUMMERS at checkout. Whether making family memories at Club Wyndham Kingsgate in Williamsburg, enjoying a getaway at Club Wyndham La Belle Maison in New Orleans, or spending time by the Pacific at Club Wyndham Oceanside Pier Resort in California, travelers can find destinations designed to bring loved ones together and create the "watch this" moments that one day become "remember when" memories.
Families can follow along and share their own 17 Summers memories with Club Wyndham on Instagram (@ClubWyndham) and Facebook (@ClubWyndham) using #17Summers.
To book a stay and take advantage of the 17 Summers vacation offer, visit ClubWyndhamVacationRentals.com/offers/17summers.
More information about Club Wyndham and its benefits can be found at ClubWyndham.com.
SURVEY METHODOLOGY: Data from a survey conducted by Talker Research on behalf of Club Wyndham from June 3 to June 12, 2026, with a sample of 2,000 parents of school-aged children who celebrate occasions and have gone on vacation within the past year.
OFFER DETAILS: Book and travel by September 22, 2026. Enter promo code 17SUMMERS at checkout for 17% off your entire stay. Two-night minimum length of stay required. Valid for new reservations only. Reservations are subject to availability. Reservations may be limited during certain holidays. Cannot be combined with any other offer. All monetary amounts are noted in U.S. Dollars unless otherwise noted. Offer rewards are available only on resort bookings made online via ClubWyndhamVacationRentals.com and rewards are distributed via email after resort arrival.
About Club Wyndham®
Club Wyndham® is the nation’s largest vacation club built around comfort, connection and together time. With access to more than 100 resorts in sought-after destinations, Club Wyndham serves as a vacation home base for travelers who treasure making memories with the people they love. Spacious resort suites offer the comforts of home, including fully equipped kitchens, separate living and dining areas, and private bedrooms, creating space to settle in, spread out and enjoy meaningful time together. Whether continuing favorite family traditions or starting new ones, Club Wyndham helps families and friends create stories that span generations and gives them countless reasons to keep coming back. All Club Wyndham resorts participate in Wyndham Rewards®, the award-winning travel loyalty program with access to more than 60,000 hotels, vacation club resorts and vacation rentals worldwide. Club Wyndham is a cornerstone vacation club brand of Travel + Leisure Co. (NYSE), the world’s largest vacation ownership business.
For more information, visit ClubWyndham.com. Connect with us on Facebook and Instagram.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Let's take a look at what these Wall Street heavyweights have to say about Waste Management (WM - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.
Waste Management currently has an average brokerage recommendation (ABR) of 1.66, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 29 brokerage firms. An ABR of 1.66 approximates between Strong Buy and Buy.
Of the 29 recommendations that derive the current ABR, 19 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 65.5% and 3.5% of all recommendations.
Brokerage Recommendation Trends for WM
Check price target & stock forecast for Waste Management here>>>
While the ABR calls for buying Waste Management, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.
Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.
This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.
Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.
Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.
The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.
Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.
On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.
There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.
Is WM a Good Investment?In terms of earnings estimate revisions for Waste Management, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $8.15.
Analysts' steady views regarding the company's earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term.
The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Waste Management. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for Waste Management.
On June 22, 2026, XP Inc XP shares rose 4.5% today, with the current price at $15.99. The stock has traded within a 52-week range of $14.80 to $23.13.
GF Value™ verdict: 51.9% undervalued with a fair value of $33.21. GF Score™ of 72/100 indicates an above-average potential for long-term returns. Most notable signal: No insider transactions in the last 3 months. Is XP Overvalued or Undervalued? XP Inc XP currently trades at $15.99, while the GF Value™ estimates its fair value at $33.21. This suggests that XP is 51.9% undervalued, indicating a substantial margin of safety for potential investors. However, the GF Valuation label indicates that this stock may also be a possible value trap, prompting investors to think twice before making decisions. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.
While the undervaluation presents an opportunity, it is important to consider the risks involved, particularly given the stock's recent performance and the warning sign from the GF Valuation label. This stock’s potential upside must be weighed against its historical volatility and current market sentiment.
How Does XP's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 8.7x 13.7x (5-Year Median) Forward P/E 7.8x N/A The current P/E (TTM) of 8.7x is significantly below its 5-year median P/E of 13.7x, indicating that the stock is trading below its historical valuation. This P/E analysis aligns with the GF Value™ verdict, reinforcing the notion that XP is undervalued in the context of its historical performance.
What Does XP's GF Score™ Tell Us? Metric Rating GF Score™ 72/100 Financial Strength 3/10 Profitability 6/10 Growth 9/10 Valuation 2/10 Momentum 7/10 The GF Score™ of 72/100 suggests that XP has above-average potential for long-term returns. Its strongest area is growth, with a score of 9/10, indicating robust future prospects. Conversely, the valuation score of 2/10 highlights significant concerns regarding its current pricing compared to intrinsic value, emphasizing caution in the investment approach.
What Are Insiders Doing with XP Stock? In the past three months, there have been no insider transactions in XP Inc XP stock. This lack of activity may suggest that insiders are either confident in the current valuation or are waiting for a more favorable market condition before making any moves. The absence of insider buying could also indicate a lack of urgency to capitalize on the company's current pricing.
What This Means for Investors Based on the GF Value™ assessment, XP Inc XP appears to be undervalued at its current price of $15.99, with a fair value estimation of $33.21. However, potential investors should remain cautious due to the identified risks and the possible value trap indicated by the GF Valuation label.
For the complete analysis, visit the XP Inc XP stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions What is XP's GF Score™?
XP's GF Score™ is 72/100, indicating above-average potential for long-term returns based on key financial metrics.
Is XP overvalued or undervalued?
XP is currently undervalued, trading at $15.99 compared to a fair value of $33.21, representing a potential upside of 51.9%.
What is XP's P/E ratio?
XP's current P/E ratio is 8.7x, which is 37% below its 5-year median of 13.7x, indicating it is trading below its historical valuation.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Williams-Sonoma (WSM - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the past month, shares of this seller of cookware and home furnishings have returned +14%, compared to the Zacks S&P 500 composite's -1.3% change. During this period, the Zacks Retail - Home Furnishings industry, which Williams-Sonoma falls in, has gained 3.4%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
For the current quarter, Williams-Sonoma is expected to post earnings of $2.03 per share, indicating a change of +1.5% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.5% over the last 30 days.
The consensus earnings estimate of $9.49 for the current fiscal year indicates a year-over-year change of +7.4%. This estimate has changed +2.2% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $10.22 indicates a change of +7.7% from what Williams-Sonoma is expected to report a year ago. Over the past month, the estimate has changed +0.6%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Williams-Sonoma.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For Williams-Sonoma, the consensus sales estimate for the current quarter of $1.91 billion indicates a year-over-year change of +4.2%. For the current and next fiscal years, $8.15 billion and $8.51 billion estimates indicate +4.4% and +4.4% changes, respectively.
Last Reported Results and Surprise HistoryWilliams-Sonoma reported revenues of $1.81 billion in the last reported quarter, representing a year-over-year change of +4.4%. EPS of $1.93 for the same period compares with $1.85 a year ago.
Compared to the Zacks Consensus Estimate of $1.8 billion, the reported revenues represent a surprise of +0.05%. The EPS surprise was +7.22%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Williams-Sonoma is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Williams-Sonoma. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Casino stock Wynn Resorts Ltd (NASDAQ:WYNN) is down 13.4% since the start of the year, recently running into resistance at the $110 region. A bounce off a historically bullish trendline may be enough to break past that ceiling, however.
According to Schaeffer's Senior Quantitative Analyst Rocky White, WYNN is trading within 3% of its 24-month moving average after spending the previous five months above that trendline. This setup has appeared four times during the last 20 years, after which the stock was higher one month later 75% of the time, averaging a 2.08% gain, and higher three months later 100% of the time, averaging an impressive 7.55% return. From the stock's current perch at $104.25, a move of 7.55% would place it at $112.12.
Short covering could give the stock a lift as well, as 11.3% of WYNN's available float is sold short. It would take shorts over five days to buy back these bearish bets, at the equity's average pace of trading.
Options are looking affordable for Wynn Resorts stock, too. Specifically, its Schaeffer's Volatility Index (SVI) of 36% which ranks in the 30th annual percentile.
In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmful visceral fat, while maintaining muscle; data continue to support once or twice-yearly dosing
Phase 2a portion in individuals with higher BMI and body fat, with and without type 2 diabetes, includes multiple assessments to inform further development of WVE-007 in obesity as well as MASH, type 2 diabetes, and cardiovascular disease
Wave is on track to initiate additional Phase 2 trials in 2H 2026 evaluating WVE-007 in combination with incretins and as post-incretin maintenance
CAMBRIDGE, Mass., June 24, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced it has initiated the Phase 2a multidose portion of the INLIGHT™ trial, a placebo-controlled (3:1) study evaluating WVE-007, an investigational GalNAc-siRNA, as monotherapy in individuals living with obesity with high BMI (35-50 kg/m2) and comorbidities.
The INLIGHT trial also includes an ongoing Phase 1 single dose portion investigating WVE-007 in otherwise healthy individuals living with overweight or obesity, with an average BMI of 32 kg/m2. In this portion of the trial, at six months of follow-up, a single 240 mg dose of WVE-007 continued to drive clinically meaningful reductions in visceral fat (-14%; p<0.05), total fat (-5%), and waist circumference (-3%). WVE-007 continues to be generally safe and well tolerated up to 600 mg and data support the potential for once or twice-yearly dosing. The Phase 2a portion of the INLIGHT trial is expected to demonstrate further body composition improvements, including greater fat loss with preserved muscle, weight loss, and improved biomarkers of cardiometabolic health.
“We have strong conviction in WVE-007’s potential to redefine obesity treatment and long-term cardiometabolic health, with early clinical results demonstrating a 14% visceral fat reduction without muscle loss six months following a single dose. The link between visceral fat and cardiometabolic outcomes is well established and further validated by a recent publication which demonstrated that for every 10% reduction in visceral fat, an individual’s risk of developing type 2 diabetes was 28% lower even a decade later,”1 said Christopher Wright, MD, PhD, Chief Medical Officer at Wave Life Sciences. “Importantly, this next portion of the INLIGHT trial will evaluate a patient population with higher BMI and greater adiposity, consistent with Phase 2 and Phase 3 obesity trials. Given WVE-007’s mechanism of targeted lipolysis, we believe this portion of the study can deliver even more pronounced improvements in body composition and we expect to gain a clearer understanding of WVE-007's potential to drive clinically meaningful weight loss, reduce fat, and preserve muscle, while informing its broader role in metabolic care.”
The Phase 2a portion of the INLIGHT trial is expected to enroll participants across the U.S. and Europe and includes multiple assessments over a 12-month period, including body weight, waist circumference, body composition (MRI and DEXA), liver fat (MRI-PDFF), HbA1c, and lipid levels. The results will inform further development of WVE-007 in obesity, as well as MASH, type 2 diabetes, and cardiovascular disease.
Wave also expects to initiate new clinical trials evaluating WVE-007 as an incretin add-on and as post-incretin maintenance in the second half of 2026.
About WVE-007
WVE-007 is an investigational GalNAc-siRNA that utilizes Wave’s best-in-class proprietary oligonucleotide chemistry and the company’s Stereopure interfering Nucleic Acid (SpiNA) next generation siRNA design. WVE-007 is designed to silence INHBE mRNA, an obesity target with strong evidence from human genetics. Individuals who have a protective loss-of-function variant in one copy of the INHBE gene have a healthier body composition and cardiometabolic profile, including less visceral fat and lower risk of type 2 diabetes or cardiovascular disease. In preclinical models, INHBE GalNAc-siRNA led to adipocyte shrinkage, fewer pro-inflammatory macrophages, less fibrosis, and improved insulin sensitivity in visceral adipose tissue, supporting potential for metabolic improvement. As an add-on to semaglutide, Wave’s GalNAc-siRNA doubled weight loss in mice and prevented weight regain upon cessation of semaglutide.
About the INLIGHT™ Clinical Trial
The INLIGHT trial is an ongoing randomized, placebo-controlled (3:1) study that includes a Phase 1, single-ascending dose portion in otherwise healthy individuals living with overweight or obesity. This portion is designed to assess safety, tolerability, pharmacokinetics, and Activin E target engagement. The INLIGHT trial is currently ongoing at multiple trial sites, including in the U.S. A Phase 2a portion of the INLIGHT trial is evaluating multiple WVE-007 doses in individuals with high BMI, with and without type 2 diabetes, and will assess metabolic and body composition improvements as well as weight loss.
About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave's PRISM® platform combines multiple RNA medicines modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities, including RNAi (SpiNA) and RNA editing (AIMers), provides Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Wave’s pipeline is focused on its obesity (WVE-007), alpha-1 antitrypsin deficiency (WVE-006) and PNPLA3 I148M liver disease (WVE-008) programs, and also includes clinical programs in Duchenne muscular dystrophy and Huntington’s disease, as well as several preclinical programs utilizing the company’s versatile RNA medicines platform. Driven by the calling to “Reimagine Possible,” Wave is leading the charge toward a world in which human potential is no longer hindered by the burden of disease. Wave is headquartered in Cambridge, MA. For more information on Wave’s science, pipeline and people, please visit www.wavelifesciences.com and follow Wave on X and LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements concerning our goals, beliefs, expectations, strategies, objectives and plans, and other statements that are not necessarily based on historical facts, including statements regarding the following, among others: the anticipated initiation, site activation, patient recruitment, patient enrollment, dosing, generation and reporting of data and/or completion of our ongoing and anticipated Phase 2 portions of our INLIGHT clinical trial and the timing and announcement of such events; our expectations to initiate new clinical trials evaluating WVE-007 as an incretin add-on and as post-incretin maintenance, and the expected results and timing thereof; our understanding of the dose levels and dosing frequency for WVE-007; our understanding of the safety profile for WVE-007; the potential of WVE-007’s mechanism (INHBE GalNAc-siRNA) as a meaningful and differentiated therapeutic approach for obesity as well as the potential to develop WVE-007 for other indications, including MASH, type 2 diabetes, and cardiovascular disease; the protocol, design and endpoints of the Phase 2a portion of our INLIGHT clinical trial; the future performance and results of WVE-007 in the Phase 2a portion of our INLIGHT clinical trial, including our expectations that there will be even greater improvements in body composition in individuals with higher BMI, visceral fat and body fat at baseline, with and without type 2 diabetes; the potential benefits of our toolkit of RNA-targeting modalities, including RNAi (SpiNA) and RNA editing (AIMers), compared to others; the benefits of RNA medicines generally; and the potential for certain of our programs to be best-in-class. The words “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual results to differ materially from those indicated by these forward-looking statements as a result of these risks, uncertainties and important factors, including, without limitation, the risks and uncertainties described in the section entitled “Risk Factors” in Wave’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC), as amended, and in other filings Wave makes with the SEC from time to time. Wave undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.
Contact:
Kate Rausch
VP, Corporate Affairs and Investor Relations
+1 617-949-4827
Investors:
James Salierno
Director, Investor Relations
+1 617-949-4043 [email protected]
1 Klein, Hadar, Liav Alufer, Dana Tamar Goldberg Toren, et al. Circulation, 2026 June 2. "Lifestyle-Induced Visceral Fat Loss as a Key Target for Durable Cardiometabolic Health: MRI-Assessed 5- and 10-Year Follow-Up After 2 Clinical Trials."
While liquefied natural gas (LNG) stocks, such as Cheniere Energy (LNG 1.64%), have been traded as a proxy for negotiations over the immediate reopening of the Strait of Hormuz, the reality is that the impact will last longer than many think. In addition, Cheniere recently provided a positive update on the most important part of the stock's investment case.
The company recently told investors about "the substantial completion of Train 6 of the Corpus Christi Liquefaction (CCL) Stage 3 Project in Texas." LNG trains are "trains" of independent equipment that take natural gas and convert it into LNG for export. The more trains, the more LNG export capacity.
Today's Change
(
-1.64
%) $
-3.84
Current Price
$
230.38
Cheniere plans seven additional mid-scale trains for CCL, adding more than 10 million tonnes per annum (mtpa) and raising CCL's capacity above 25 mtpa, as well as the overall company capacity to 55 mtpa. Another two trains (8 & 9) will add 5 mtpa by the end of 2028, and expansion projects at Sabine Pass (SBL) mean the company has "line of sight to potentially surpass 100 mtpa of LNG production capacity by the mid-2030s."
For reference, Qatar exported about 110 mtpa via the Strait in 2025.
Why it matters to investors Cheniere de-risks its expansion projects by signing long-term offtake agreements before making an investment decision, so one of the greatest risks in its business is the execution and timing of expansions. As such, the news that CCL is on track is excellent.
Image source: Getty Images.
Moreover, thinking longer-term, a reopening of the Strait will obviously ease concerns about LNG supply. Still, it will take years for Qatar to fully restore the 17% of its capacity damaged by attacks. In addition, energy companies usually sign long-term LNG supply contracts, and they might not be as willing to do so with Qatar/UAE now, given the ongoing instability in the region and Iran's demonstrated ability and willingness to close the Strait. And there's the question of insurers charging extra premiums for shipping through the Strait.
As such, even if a ceasefire holds and the Strait is permanently reopened, the threat of future disruption may still confer a competitive advantage on Cheniere. It may also negatively affect Qatar's financial viability in pursuing its own expansion plans.
Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Cheniere Energy. The Motley Fool has a disclosure policy.
The outbreak of hostilities between the U.S. and Iran at the end of February sent energy markets into turmoil. When the Strait of Hormuz was temporarily closed, traders suddenly faced the prospect of a major disruption to global oil supplies. Brent crude briefly surged above $100 per barrel as did U.S. benchmark West Texas Intermediate (WTI) crude.
Those fears have eased as ceasefire negotiations and ongoing diplomatic talks reduced the risk of a prolonged conflict. Brent has since retreated to roughly $77 per barrel while WTI has fallen to around $73. Yet one corner of the energy market may still be benefiting from the aftershocks: U.S. liquefied natural gas exporters.
Europe Is Now Dependent on American LNG Oil grabbed the headlines during the Iran conflict, but natural gas may prove to be the more important long-term story.
According to data from Columbia University’s Center on Global Energy Policy, U.S. LNG accounted for roughly 64% of Europe’s imported LNG supplies during the height of the Iran crisis and Strait of Hormuz disruption. Even today, that figure remains just below 60%.
The shift did not happen overnight. Europe was already replacing Russian gas supplies following sanctions tied to Russia’s invasion of Ukraine. The Middle East conflict only accelerated that trend.
The Center’s data also shows the U.S. has become Europe’s second-largest overall gas supplier behind Norway. That dependence has created a powerful structural tailwind for exporters such as Cheniere Energy (NYSE:LNG | LNG Price Prediction), the largest U.S. LNG exporter.
Yet investors would never know it from the stock chart. By the end of March, shares of Cheniere had peaked alongside global gas prices. Since then, Cheniere has fallen 23%, while Venture Global (NYSE:VG) has declined 42%.
Why Investors Turned Bearish First, U.S. LNG exporters face a capacity problem. America has abundant natural gas reserves but lacks enough liquefaction facilities to export substantially more fuel than it already does. Most major export terminals are operating near full capacity. That means companies cannot dramatically increase volumes even when international prices spike.
Meanwhile, domestic production remains elevated. Combined with mild weather, U.S. storage inventories have risen above historical averages, keeping domestic natural gas prices under pressure.
Investors also recognized that some of the extraordinary profits generated during the Iran conflict were unlikely to be repeated. Companies such as Venture Global benefited from selling uncontracted cargoes into the spot market when prices surged. As global gas prices normalized, those windfall revenues disappeared.
That shift is especially concerning for heavily leveraged exporters whose balance sheets looked stronger when spot prices were setting records.
Winter Could Change the Narrative Surprisingly, the strongest catalyst for Cheniere may not be another geopolitical crisis. It could simply be winter.
Europe entered 2026 with natural gas storage levels near five-year lows. Industry estimates suggest inventories were roughly 140 LNG cargoes below normal safety levels after spring supply disruptions. That leaves European utilities vulnerable if temperatures fall below seasonal norms.
For Cheniere, a winter-driven demand surge would look very different from the speculative rally fueled by the Iran conflict. Instead of relying on volatile spot prices, the company would benefit from maximum utilization of its long-term contracted export capacity and stronger cash collections. That is because stable cash flow tends to support valuations more effectively than short-lived commodity spikes.
Wall Street appears to agree. Analysts continue to maintain a consensus Buy rating on Cheniere, with average price targets near $303 per share, implying 31% upside.
Key Takeaway In short, Cheniere Energy’s 23% decline reflects concerns about export capacity limits, lower spot gas prices, and fading Iran-war profits. Those concerns are real.
Yet Europe’s dependence on American LNG remains intact. U.S. suppliers still account for nearly 60% of Europe’s LNG import.. With European storage levels entering winter near multi-year lows and Qatar’s damaged export infrastructure unlikely to be fully restored anytime soon, demand for Gulf Coast LNG remains firmly in place.
Ultimately, Cheniere doesn’t need another Middle East crisis to recover. It simply needs a cold European winter and continued demand for American gas. For patient investors, that may be enough.
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
It also includes access to the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Yum China Holdings (YUMC - Free Report) Yum China Holdings, Inc., incorporated in Delaware on Apr 1, 2016, became an independent and publicly-traded company; post its spin-off from Yum! Brands, Inc. on Oct 31, 2016. Yum China’s U.S. operations are based in Texas. The company operates both company-owned and franchised restaurants.
YUMC is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 14.02; value investors should take notice.
Two analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.02 to $2.96 per share. YUMC boasts an average earnings surprise of +4%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, YUMC should be on investors' short list.
IRVING, Texas--(BUSINESS WIRE)--Last week, McKesson Corporation hosted McKesson ideaShare 2026, the company’s annual event for independent community pharmacies, in Denver, Colorado. McKesson ideaShare is a premier event for independent community pharmacy professionals, bringing together leaders from across the country for education, networking and collaboration focused on helping independent pharmacies innovate and thrive.
“Independent pharmacies play an essential role in care delivery, with patients relying on them not just for prescriptions, but for personalized support with an increasing range of services,” said Crystal Lennartz, PharmD, MBA, president, Health Mart and Health Mart Atlas. “At McKesson ideaShare, we brought the independent pharmacy community together to learn from one another, pairing meaningful connection with actionable education on business, patient care and advocacy. This helps pharmacy teams strengthen their businesses, amplify their voice and continue serving patients.”
Advancing Pharmacy Through Innovation and Advocacy
McKesson ideaShare 2026 focused on the strategies, tools and connections independent community pharmacies need to navigate a changing healthcare landscape and create lasting value for patients and communities. The event highlighted emerging technologies such as artificial intelligence (AI), with opportunities for attendees to participate in tech-focused education, explore new tools and experience hands-on interactions with AI-powered solutions for their pharmacies.
The event also highlighted how advocacy efforts are helping to advance and protect independent community pharmacy at the local, state and national levels. McKesson is continuing its commitment to supporting state pharmacy associations and their advocacy efforts through dedicated funding via McKesson Amplify. Applications for 2027 McKesson Amplify funding are now open, and eligible state pharmacy associations are encouraged to apply.
Mace’s Pharmacy Awarded Health Mart Pharmacy of the Year
During McKesson ideaShare, Health Mart presented the 2026 Health Mart Pharmacy of the Year award. The annual award recognizes independent community pharmacies that demonstrate excellence in patient care, business innovation and community impact. Attendees chose the winner through a live, onsite vote.
This year’s title was awarded to Mace’s Pharmacy of Barbour County, West Virginia. Owners Rich Mace, PharmD, Kathy Mace and their team are dedicated to meeting the healthcare needs of Barbour County and the surrounding community. For nearly 25 years, Mace’s Pharmacy has grown alongside the families it serves—providing personalized care, expanding clinical services and remaining deeply invested in the well‑being of its community.
“Our approach to care is rooted in service. We believe we have been placed in our community for a purpose— to care for patients, show up in times of need and serve others. That belief guides how we treat patients, how we support our community, and how we make decisions as a business,” said Rich Mace.
Additional finalists were Butterfield’s Pharmacy of Port St. Lucie, Florida, and Latham’s Pharmacy of Arab, Alabama.
Recognizing Excellence in Community Pharmacy
Additional acknowledgements at McKesson ideaShare 2026 included the Trailblazer Award, presented to Shahida Choudhry, PharmD, and the Going the Distance Award, presented to CHCC Outpatient Pharmacy. Choudhry, owner of Palms Pharmacy in Tampa, Florida, was recognized for redefining what is possible in independent pharmacy through innovative care delivery and national leadership. CHCC Outpatient Pharmacy, located in Saipan, Commonwealth of the Northern Mariana Islands, was honored for expanding access to care and maintaining uninterrupted service despite geographic isolation, severe weather, and supply chain challenges, reinforcing its role as a dependable healthcare resource.
McKesson ideaShare 2026 Product Showcase
The McKesson ideaShare 2026 Product Showcase highlighted solutions designed to help independent community pharmacies strengthen their operations, expand patient care and meet evolving community needs. For the first time at McKesson ideaShare, attendees evaluated these tools and voted on the solutions they believe could have the greatest impact on their business and the patients they serve. Additional details including category winners and honored solutions can be viewed online.
Save the Date for McKesson ideaShare 2027
Following the momentum of McKesson ideaShare 2026, the event will return to Mandalay Bay in Las Vegas, Nevada from June 24-27, 2027.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Stories & Insights.
About Health Mart
Health Mart® is a network of nearly 4,000 high-performing, locally owned independent community pharmacies across the nation. Health Mart pharmacies offer individualized care tailored to patients’ unique needs, with pharmacists who serve as critical members of the healthcare team. Health Mart pharmacists work with patients and other providers, using their clinical skills to support better health outcomes.
Health Mart pharmacies have been ranked #1 in Customer Satisfaction in the J.D. Power 2025 U.S. Pharmacy Study Among Chain Drug Store Pharmacies. The Health Mart franchise is owned by Health Mart Systems, Inc., which is part of McKesson Corporation. Pharmacists and pharmacy owners interested in learning more can explore join.healthmart.com.
About Health Mart Atlas
Health Mart Atlas™ is a market-leading managed care solution leveraged by nearly 6,000 community-based pharmacies nationwide, navigating contracting and patient access to help drive success and operational effectiveness. Health Mart Atlas provides the expertise, tools and insights needed to help pharmacies remain top clinical performers and compete in an evolving market. Health Mart Atlas is owned by McKesson Corporation.
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2027 financial results after market close on Wednesday, August 5, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
The live and archived audio webcast will be available on McKesson’s Investor Relations website.
About McKesson Corporation
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Stories & Insights.
We routinely use our website, investor.mckesson.com, to post information that may be material to investors, such as business developments, earnings, and financial performance, as well as presentation materials and details for upcoming and past events.
McKesson (MCK - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Shares of this prescription drug distributor have returned +1.3% over the past month versus the Zacks S&P 500 composite's -1.3% change. The Zacks Medical - Dental Supplies industry, to which McKesson belongs, has gained 3.4% over this period. Now the key question is: Where could the stock be headed in the near term?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
McKesson is expected to post earnings of $9.63 per share for the current quarter, representing a year-over-year change of +16.6%. Over the last 30 days, the Zacks Consensus Estimate has changed -0%.
For the current fiscal year, the consensus earnings estimate of $44.28 points to a change of +13.2% from the prior year. Over the last 30 days, this estimate has remained unchanged.
For the next fiscal year, the consensus earnings estimate of $49.95 indicates a change of +12.8% from what McKesson is expected to report a year ago. Over the past month, the estimate has changed +0.1%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, McKesson is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For McKesson, the consensus sales estimate for the current quarter of $104.39 billion indicates a year-over-year change of +6.7%. For the current and next fiscal years, $432.83 billion and $464.69 billion estimates indicate +7.3% and +7.4% changes, respectively.
Last Reported Results and Surprise HistoryMcKesson reported revenues of $96.3 billion in the last reported quarter, representing a year-over-year change of +6%. EPS of $11.69 for the same period compares with $10.12 a year ago.
Compared to the Zacks Consensus Estimate of $101.92 billion, the reported revenues represent a surprise of -5.52%. The EPS surprise was +1.12%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates two times over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
McKesson is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about McKesson. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Study of 1,500 hotel decision makers across six markets finds that full connectivity – not just basic connectivity – drives stronger revenue performance, less manual work and lowers operational risk
SEATTLE--(BUSINESS WIRE)--Expedia Group today released new global research showing that full connectivity is a decisive performance differentiator for hotel properties in driving revenue, maximizing operational efficiency, and delivering reliable inventory. Findings from independent hotels, franchise properties, and mid-to-large chains show that properties using a full suite of connectivity report stronger business performance, less friction, and greater confidence.
"Our goal is to continue removing friction from travel distribution by developing APIs that address the most critical needs of our hotel partners and connectivity providers."
ShareBased on insights from 1,500 hotel decision makers across six markets, the research examines how different levels of connectivity software adoption – full, basic, or no connectivity – affect workload, channel performance, and perceptions of value.
“As booking channels proliferate, travel distribution is becoming increasingly complex, and hoteliers using connectivity providers and API capabilities can automate workflows, streamline operations, reduce pressure on their teams and improve profitability,” said Chris Hodges, Vice President of Global Connectivity & Partner Solutions, Expedia Group. “Our goal is to continue removing friction from travel distribution by developing APIs that address the most critical needs of our hotel partners and connectivity providers.”
Connectivity is a profit driver for hotels
81% of fully connected properties say connectivity has improved their property’s occupancy, average daily rate (ADR), or revenue per available room (RevPAR).52% of properties relying on basic connectivity say that technology has improved their occupancy, ADR, or RevPAR.83% of fully connected properties believe better connectivity improves their bottom line, compared to 55% with basic connectivity and 26% of unconnected properties.Connectivity helps hotels cut friction and save time
81% of decision makers from fully connected properties say working with a connectivity provider has reduced both friction and manual work, compared to 49% of properties using basic connectivity.Roughly 74% of unconnected properties report doing tasks on OTAs either partially or entirely manually.Approximately 50% of fully connected properties have tasks on OTAs fully or mostly automated.Connectivity gives hotels more control with less risk
95% of fully connected properties feel confident that rate and availability changes are made across all channels within 15 minutes, compared to 90% of properties with basic connectivity, and 80% of unconnected properties.OTA issues for unconnected properties: 14% are more likely to experience overbookings caused by mismatched availability and 9% are more likely to experience reservations not being delivered or delayed in their PMS or front office system.Perceived barriers preventing hotels from adopting connectivity
32% of hotel decision makers say concern about losing control over pricing or inventory is the top reason they haven’t adopted connectivity software.27% have plans to adopt connectivity but have not done so yet, and 25% cite limited internal IT resources or technical expertise as their main barrier to software adoption.Notably, 24% of hoteliers do not see sufficient benefit to connectivity.Expedia Group is supporting hotels on their journey to full connectivity
Expedia Group is embarking on a three-phase journey to reduce friction in hotels day-to-day operations through Autonomous Distribution. Each category will unlock a different layer of support:
Autonomous Onboarding will enable properties to onboard and go live in minutes.Autonomous Management will streamline day-to-day operations through software.Autonomous Optimization will improve performance through promotional levers and expanded distribution.For a deeper look at the full research findings and Expedia Group’s API offerings for hotels, visit the Expedia Group partner blog.
Methodology
Censuswide conducted a survey from March 26 to April 7, 2026, of 1,500 hotel decision makers representing various hotel sizes in 6 markets (U.S., Canada, Mexico, France, Italy, and South Korea). Participants included individuals from properties with full, basic or no connectivity.
About Expedia Group
Expedia Group, Inc. (NASDAQ: EXPE) is the global travel marketplace with one purpose: to help travelers explore the world, one journey at a time. Expedia Group™ connects travelers, partners, and advertisers through its trusted brands, leading technology, and rich first-party data, delivering predictive, personalized experiences that shape the future of travel.
Expedia Group’s ecosystem includes three flagship consumer brands – Expedia®, Hotels.com®, and Vrbo® – the largest B2B travel business, and a premier advertising network. Guided by an experienced and passionate global team, Expedia Group helps millions of travelers in more than 70 countries explore the world with confidence and ease.
For more information, visit www.expediagroup.com.
Follow Expedia Group on Facebook, Instagram, X and LinkedIn.
Follow Expedia on Facebook, Instagram, TikTok, Pinterest, X and YouTube.
Follow Vrbo on Facebook, Instagram, TikTok, Pinterest, and X.
Follow Hotels.com on Instagram, TikTok, Facebook and X.
, /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced the appointment of Lauren M. Tyler to its Board of Directors, effective June 19, 2026. Ms. Tyler will serve on the Audit Committee and Compensation and Talent Committee.
Ms. Tyler brings more than 30 years of leadership experience across investment banking, private equity, corporate audit, investor relations, and human capital strategy.
CENTENE APPOINTS LAUREN M. TYLER TO BOARD OF DIRECTORS "Lauren's longstanding track record guiding global, complex organizations through transformation while prioritizing governance, talent development, and operational rigor will be key as Centene continues to evolve and deliver on its mission," said CEO Sarah M. London.
Ms. Tyler spent over two decades at JPMorgan Chase & Co., where she held senior roles including Executive Vice President and Global Head of Human Resources for Asset and Wealth Management, Global Firmwide Chief Auditor, and Global Head of Investor Relations. Earlier in her career, she held roles at TSG Capital Partners, Allen & Company, and Morgan Stanley.
She currently serves on the boards of Cencora, Inc., and Guardian Life. She previously served on the board of Alleghany Corporation until its acquisition in 2022. Ms. Tyler holds an MBA from Harvard Business School and a BA from Yale University.
"Lauren's seasoned board experience and proven leadership guiding complex organizations through dynamic operating environments will make her a strong addition to our Board," said Chairman Frederick H. Eppinger.
"I am honored to join Centene's Board, a company whose mission I deeply admire, and look forward to working closely with the company's leadership to make an impact on improving the health of the communities it serves nationwide," said Ms. Tyler.
About Centene Corporation
Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach with local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.
Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://investors.centene.com/.
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Centene (CNC - Free Report) Centene Corporation is a well-diversified healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services.
CNC is a #1 (Strong Buy) on the Zacks Rank, with a VGM Score of A.
It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 18.38; value investors should take notice.
Nine analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.46 to $3.47 per share. CNC boasts an average earnings surprise of +74.9%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, CNC should be on investors' short list.
, /PRNewswire/ -- Following Gov. Newsom's declaration of a State of Emergency in Los Angeles County, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), is taking immediate action to support those affected by the fire. The company's priority is ensuring both its members and healthcare providers have the resources they need during this critical time.
Member Prescription Information
During a declared State of Emergency, impacted members have two options to secure an emergency supply of their medications:
Members can fill their prescription at the original pharmacy if it is open. If the original pharmacy is not open, members can call Health Net at 1-800-400-8987. We will suspend refill limitations so they can get their prescriptions at an out-of-network pharmacy. Coping Support for Members
Members can call Health Net Behavioral Health Services for crisis support 24 hours a day, seven days a week by calling 1-800-400-8987 (TTY: 711). This includes:
Support to help them deal with grief, stress or trauma Referrals to mental health counselors, local services and telephone consultations Members: Video Medical Appointments
If members cannot reach their primary care provider during a declared State of Emergency, Health Net offers telehealth services at no cost. Members can find appointment instructions in two places:
On the back of their Health Net ID card On HealthNet.com after registering and signing in Access to Social Services
To connect with local community resources, members can call 2-1-1 or visit 211.org for help with:
Emergency shelter, food and transportation Social services and financial assistance Legal guidance from verified agencies Information for Healthcare Providers
During a declared State of Emergency, doctors and nurse practitioners may call Health Net at 1-800-641-7761 for assistance. To support these participating providers in affected areas, Health Net will:
Extend grace periods for notifications, beginning on the admission date, for acute services, post-acute care, durable medical equipment (DME), medical supplies and home health care services Waive prior authorization – however, our notification requirement will remain in effect despite relaxed deadlines In addition, Health Net will:
Authorize out-of-network services if a contracting provider or facility becomes unavailable Grant post-admission notification approvals for impacted facilities. Accept updated clinical documentation for continued-stay reviews. Authorize the replacement of medical equipment or supplies. Suspend prescription refill limitations for impacted enrollees Ongoing Support & Updates
As the situation evolves, Health Net may take further action to support members and providers. For the latest updates, visit HealthNet.com.
About Health Net
Founded in California more than 45 years ago, Health Net, a company of Centene Corporation, believes that every person deserves a safety net for their health, regardless of age, income, employment status or current state of health. Today, we provide health plans for individuals, families, businesses of every size and people who qualify for Medi-Cal or Medicare. With more than 117,000 of our network providers, Health Net serves more than three million members across the state. We also offer access to substance abuse programs, behavioral health services, employee assistance programs and managed healthcare products related to prescription drugs. We make these health plans and services available through Health Net, LLC and its subsidiaries: Health Net of California, Inc., Health Net Life Insurance Company and Health Net Community Solutions, Inc. These entities are wholly owned subsidiaries of Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to transforming the health of the communities we serve, one person at a time. Health Net and Centene employ more than 5,700 people in California who work at one of five regional Talent Hub offices. For more information, visit www.HealthNet.com.
, /PRNewswire/ - Canada Nickel Company Inc. ("Canada Nickel" or the "Company") (TSXV: CNC) (OTCQX: CNIKF) has appointed SB1 Markets AS ("SB1 Markets") as exclusive advisor to arrange debt financing of up to US$600 million. The facility would allow the Company to monetize Investment Tax Credits expected to be generated by the construction of its Crawford Nickel Project. The Company expects the financing to be arranged by the end of 2026, in advance of a final investment decision on Crawford targeted for 2027. There can be no assurance that the proposed financing will be completed, and, if completed, the terms of such financing would be included in a subsequent release.
Mark Selby, CEO and Director of Canada Nickel Company said, "We are very pleased to work with SB1 Markets, a global leader with deep experience and a highly successful track record in providing debt financing for natural resource projects. With a final permitting decision expected shortly, we can now move more aggressively on key components of our project financing as we advance towards a final investment decision. This bridge financing is central to Crawford's overall capital structure; it allows us to deploy Canada's generous investment tax credits available for critical mineral projects in Canada to fund more than half of the equity capital we need to build Crawford."
About SB1 Markets
SB1 Markets AS is a leading Nordic investment bank, jointly owned by SpareBank 1 and Swedbank and providing investment banking services across DCM, ECM, advisory, research, sales, corporate access, and FICC. The firm is headquartered in Norway and Sweden with around 270 professionals. SB1 Markets has arranged transactions for a total value of approximately USD 70bn over the last twelve months and financing natural resource companies and projects is a core part of the company's business.
About Canada Nickel
Canada Nickel is advancing the next generation of nickel-sulphide projects to deliver nickel required to feed the high growth electric vehicle and stainless steel markets. Canada Nickel has applied in multiple jurisdictions to trademark the terms NetZero NickelTM, NetZero CobaltTM and NetZero IronTM and is pursuing the development of processes to allow the production of net zero carbon nickel, cobalt, and iron products. Canada Nickel provides investors with leverage to nickel in low political risk jurisdictions. Canada Nickel is currently anchored by its 100% owned flagship Crawford Nickel-Cobalt Sulphide Project in the heart of the prolific Timmins-Cochrane mining camp. For more information, please visit www.canadanickel.com.
For further information, please contact:
Mark Selby
CEO
Phone: 647-256-1954
Email: [email protected]
This press release contains certain information that may constitute "forward-looking information" under applicable Canadian securities legislation. Forward looking information includes the ability of the Company to qualify for critical minerals tax credits, complete the financing described in this release and otherwise finance and construct the Crawford Nickel Project, deliver nickel required to feed the high growth electric vehicle and stainless steel markets, and the development of processes to allow the production of net zero carbon nickel, cobalt, and iron products. Readers should not place undue reliance on forward looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canada Nickel to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. There are no assurances that Crawford will be placed into production. Factors that could affect the outcome include, among others: inability to repay the loan or comply with the covenants set out in the loan agreement; the ability to obtain the approval of the TSX Venture Exchange for the matters described herein; the actual results of development activities; project delays; inability to raise the funds necessary to complete development; general business, economic, competitive, political and social uncertainties; future prices of metals or project costs could differ substantially and make any commercialization uneconomic; availability of alternative nickel sources or substitutes; actual nickel recovery; conclusions of economic evaluations; changes in applicable laws; changes in project parameters as plans continue to be refined; accidents, labour disputes, the availability and productivity of skilled labour and other risks of the mining industry; political instability, terrorism, insurrection or war; delays in obtaining governmental approvals, necessary permitting or in the completion of development or construction activities; mineral resource estimates relating to Crawford could prove to be inaccurate for any reason whatsoever; additional but currently unforeseen work may be required to advance to the feasibility stage; and even if Crawford goes into production, there is no assurance that operations will be profitable. Although Canada Nickel has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Forward-looking statements contained herein are made as of the date of this news release and Canada Nickel disclaims any obligation to update any forward looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
On June 22, 2026, Kinsale Capital Group Inc KNSL shares fell 4.5%, closing at $295.05. This decline comes amidst a challenging year for the stock, which has seen a year-to-date decrease of 24.4% and a one-year decline of 37.9%. The stock's price has fluctuated between a 52-week high of $512.76 and a low of $287.20.
GF Value™ verdict: Current price of $295.05 is 48.3% below the GF Value™ estimate of $571.17.GF Score™: 80/100, indicating a strong overall evaluation.Most notable signal: Insider activity shows that insiders bought $0.1M and sold $6.9M in the last 3 months. Is KNSL Overvalued or Undervalued? Kinsale Capital Group Inc KNSL is currently trading at $295.05, which is significantly below its GF Value™ estimate of $571.17, indicating that the stock is 48.3% undervalued. This gap suggests a potential opportunity for investors looking for undervalued assets. The GF Valuation label classifies KNSL as "Significantly Undervalued," which reflects a substantial margin of safety for potential investors. However, it is crucial to consider that valuation disparities can arise from various factors, including market sentiment and company-specific challenges.
GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates. While undervalued stocks may present buying opportunities, they can also carry risks such as prolonged periods of underperformance or adverse business developments that could affect future valuations.
How Does KNSL's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 13.0x 30.0x Forward P/E 14.2x - Kinsale Capital's current P/E ratio of 13.0x is significantly below its 5-year median P/E of 30.0x, indicating that the stock is trading at a much lower valuation compared to its historical levels. This analysis aligns with the GF Value™ verdict of being undervalued, suggesting that the stock's current price may not reflect its true earnings potential based on historical performance.
What Does KNSL's GF Score™ Tell Us? Metric Rating GF Score™ 80/100 Financial Strength 6/10 Profitability 7/10 Growth 9/10 Valuation 4/10 Momentum 4/10 The GF Score™ of 80/100 indicates that Kinsale Capital Group demonstrates strong overall characteristics, particularly in the Growth category, where it scores 9/10. However, the Valuation and Momentum rankings are weaker at 4/10, suggesting that while the company may have solid growth prospects, its current price performance and valuation metrics may not be as favorable. This mixed set of scores points to a nuanced investment profile that potential investors should consider carefully.
What Are Insiders Doing with KNSL Stock? Recent insider activity at Kinsale Capital Group reveals a significant disparity between buying and selling. Insiders have purchased approximately $0.1 million worth of shares while selling $6.9 million over the past three months. This pattern may suggest a lack of confidence from insiders regarding the company's short-term prospects, as substantial selling could indicate that they anticipate further challenges ahead. Investors may interpret this as a warning sign, particularly in the context of the stock's recent performance.
What This Means for Investors Based on the analysis of GF Value™, Kinsale Capital Group Inc KNSL is currently undervalued. With a current price of $295.05 compared to a GF Value™ of $571.17, there is a significant margin of safety. However, potential investors should remain cautious due to recent insider selling and the stock's downward price momentum.
For the complete analysis, visit the Kinsale Capital Group Inc KNSL stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions What is KNSL's GF Score™?
Kinsale Capital Group Inc's GF Score™ is 80/100, which indicates a strong overall evaluation based on key financial metrics.
Is KNSL overvalued or undervalued?
Kinsale Capital Group Inc is currently undervalued, with a GF Value™ estimate of $571.17 compared to its current price of $295.05.
What is KNSL's P/E ratio?
Kinsale Capital Group Inc has a P/E (TTM) ratio of 13.0x, which is significantly lower than its 5-year median P/E of 30.0x, indicating that it is trading well below its historical valuation levels.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
On June 23, 2026, Rambus Inc RMBS shares fell 8.6% today, currently priced at $128.29. The stock has experienced a 52-week range between $60.96 and $174.10, highlighting significant volatility over the past year. The recent drop adds to a one-month decline of 10.3% and a weekly decrease of 3.2%.
GF Value™ verdict: Shares are currently priced at $128.29, which represents a 37.5% overvaluation compared to the GF Value™ of $93.31.GF Score™: 85/100, indicating a strong overall ranking based on key financial metrics.Notable signal: Insiders sold $13.3 million in stock over the past three months, signaling potential caution regarding the company's future prospects. Is RMBS Overvalued or Undervalued? The current price of Rambus Inc at $128.29 is well above the GF Value™ estimate of $93.31, which indicates that the stock is overvalued by approximately 37.5%. This significant difference raises concerns about the sustainability of the current price level, particularly in light of the GF Valuation label stating that the stock is "Significantly Overvalued." The margin of safety appears limited, which suggests potential risks for current shareholders.
GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates. The considerable gap between the current price and the GF Value™ raises red flags, indicating that the market may be pricing in overly optimistic future growth expectations for Rambus. Investors should be cautious, as overvaluation can lead to declines if market sentiment shifts or if the company fails to meet growth projections.
How Does RMBS's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 61.0x 33.9x Forward P/E 43.0x N/A The current P/E (TTM) of Rambus is 61.0x, which is 80% above its 5-year median P/E of 33.9x. Additionally, the forward P/E of 43.0x suggests that analysts expect earnings to improve in the future. However, this analysis aligns with the GF Value™ verdict that the stock is overvalued. The elevated P/E ratios indicate that the market is pricing in high growth expectations, which may not be sustainable.
What Does RMBS's GF Score™ Tell Us? Metric Rating GF Score™ 85/100 Financial Strength 10/10 Profitability 6/10 Growth 10/10 Valuation 3/10 Momentum 9/10 The GF Score™ of 85/100 reflects a strong overall performance for Rambus, particularly in areas such as Financial Strength and Growth, where it scored 10/10. However, the Valuation score of 3/10 indicates significant concerns regarding its current pricing relative to its intrinsic value. The disparity between strong financial metrics and an unfavorable valuation suggests that while the company may be performing well operationally, its stock price may not be justified by its fundamentals.
What Are Insiders Doing with RMBS Stock? In the last three months, insiders have sold $13.3 million worth of shares without any buying activity, which can be interpreted as a bearish signal. This trend of selling may indicate a lack of confidence from those who have the most insight into the company's operations. The absence of insider buying further emphasizes the caution surrounding the stock's current valuation and future performance.
What This Means for Investors Based on the GF Value™ assessment, Rambus Inc is currently overvalued. The significant gap between the current share price and the estimated intrinsic value raises concerns about the sustainability of the current price level. Investors may need to proceed with caution in light of these factors.
For the complete analysis, visit the Rambus Inc RMBS stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions What is RMBS's GF Score™?
RMBS has a GF Score™ of 85/100, indicating a strong overall ranking based on key financial metrics.
Is RMBS overvalued or undervalued?
According to the GF Value™ estimate, RMBS is overvalued, with a current price of $128.29 compared to a GF Value™ of $93.31.
What is RMBS's P/E ratio?
The P/E ratio for RMBS is 61.0x, which is significantly above its 5-year median P/E of 33.9x, indicating that the stock is trading at a premium compared to its historical valuation.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Warren Buffett was the head honcho at Berkshire Hathaway (BRKA +1.06%)(BRKB +0.87%) for more than 60 years, and during that time, he turned it from a failing business into a trillion-dollar conglomerate. Buffett was known for his investing discipline and ability to find gems in the market, and tons of investors mirrored Berkshire's investment moves simply because Buffett had a hand in making them.
Now, Buffett has passed the keys to the new CEO, Greb Abel, and serves in a lesser role. There will inevitably be shades of Buffett lingering, but Abel and Berkshire have made moves that show the company is embracing a new era post-Buffett. And instead of telling us with words, they're showing us with actions.
Image source: The Motley Fool.
A slight shift in Berkshire's top holdings Berkshire's top four holdings have been staples in its portfolio for quite some time, but the newest member of the top five, Alphabet (GOOG +1.01%)(GOOGL +1.19%), is reshaping its core. Here are Berkshire's top five holdings:
CompanyShares OwnedPercentage of Berkshire's Stock PortfolioApple227,917,80820.2%American Express151,610,70015.3%Coca-Cola400,000,0009.5%Bank of America513,624,1658.6%Alphabet57,835,0137.5% Source: Berkshire Hathaway.
Although Berkshire began purchasing Alphabet shares last year, the extent of its stake increase has surprised many, as Berkshire has historically steered clear of high-growth tech stocks.
Some surprising names are no longer around When Berkshire's most recent 13F filing got released, it showed its biggest portfolio turnover in quite some time. The conglomerate sold its entire stake in the following companies:
Visa Mastercard Amazon UnitedHealth Group Domino's Pizza Aon Diageo Pool Berkshire doesn't issue "we sold X because of X" statements, but there are hints as to why certain moves were made.
The dumping of Visa and Mastercard, for example, is reportedly due to the departure of former Berkshire manager Todd Combs, who left the company for JPMorgan Chase at the end of last year. Combs was known as the payments expert, so it may be a case of Berkshire cleaning house of the industry since the top person was no longer around.
Amazon was a bit of a surprise to me, given the growing stake in Alphabet, but the stock has underperformed in recent years, so Berkshire may feel the money is better off elsewhere. Berkshire had just bought a stake in UnitedHealth Group in mid-2025, so there weren't any long-standing ties with the company, unlike with others. There's still a lot of question marks surrounding UnitedHealth that Berkshire may not have wanted to wait out right now.
The remaining companies were much smaller parts of Berkshire's portfolio and may simply not fit the vision of where the company's investment philosophy is headed.
Today's Change
(
0.87
%) $
4.30
Current Price
$
497.11
A different approach to investing Buffett was known for his value investing and for backing "boring" companies with predictable business models, strong cash flow, and competitive moats.
Coca-Cola's business isn't exciting, but it has stood the test of time and continues to make billions. Banking isn't necessarily exciting, but Bank of America is permanently ingrained in the country's fabric. And Chevron (which Alphabet replaced in Berkshire's top five holdings) may not draw fireworks, but it's one of the most cash-flow-heavy companies around.
By no means are Abel and Berkshire abandoning these philosophies; they are just applying them in the digital age. Alphabet is routinely a top-10 revenue-generating public company in the world, and it operates a monopoly in its search business.
Berkshire has been sitting on an unprecedented cash pile for years (it was $397.4 billion at the end of Q1), so it's not in a hurry to invest just for the sake of it. But given that the company has considerably underperformed the market over the past few years, it makes sense that new leadership would want to shake things up a bit.
I wouldn't sell any Berkshire shares if you own them, but I also wouldn't buy any more right now until we see how the rest of the portfolio moves pan out.
Bank of America is an advertising partner of Motley Fool Money. JPMorgan Chase is an advertising partner of Motley Fool Money. American Express is an advertising partner of Motley Fool Money. Stefon Walters has positions in Apple, Coca-Cola, and Visa. The Motley Fool has positions in and recommends Alphabet, Amazon, American Express, Apple, Berkshire Hathaway, Chevron, Domino's Pizza, JPMorgan Chase, Mastercard, Pool, and Visa. The Motley Fool recommends Diageo Plc and UnitedHealth Group. The Motley Fool has a disclosure policy.
Berkshire Hathaway’s Q1 2026 13F filing, dated May 15, 2026, covering positions held as of March 31, 2026, offers the cleanest read yet on how Greg Abel is steering Berkshire’s $300+ billion equity book. The early-summer ritual of dissecting those moves has investors hunting for signals on where the most patient institutional capital sees value. Three names stood out for the size and conviction of the buying. 13F snapshots are point-in-time and may not reflect current holdings, but the message is clear: Berkshire is leaning into beaten-down cyclicals and one mega-cap AI compounder.
Delta Air Lines Delta Air Lines (NYSE:DAL | DAL Price Prediction) is the headline grabber. Berkshire exited every airline during COVID, and Abel’s team just reversed course with a brand-new position of 39,809,456 shares worth roughly $2.65 billion. That is a deliberate, high-conviction re-entry.
The fundamentals back the call. Delta’s Q1 FY26 earnings report delivered adjusted EPS of $0.64, up 44% year over year, on revenue of $14.20 billion (+9%) with free cash flow of $1.227 billion. premium ticket revenue rose 14%, loyalty revenue rose 13%, and the American Express remuneration crossed $2.00 billion (+10%). Diversified high-margin revenue now accounts for 62% of total adjusted revenue. CEO Ed Bastian guided the June quarter to “$1 billion of profit” with EPS of $1.00 to $1.50, and the full-year framework calls for EPS of $6.50 to $7.50 and free cash flow of $3 billion to $4 billion.
The market is validating the thesis. Delta is up 23% since the 13F filing date and 26% year to date, with shares at $89.05 against a $58.23 billion market cap. Sentiment is leaning the same way, with a composite sentiment score of 62.03 (bullish, medium confidence).
Risk: Fuel is the swing variable. Adjusted fuel expense rose 8% to $2.59 billion last quarter, and management flagged a projected $2 billion-plus year-over-year fuel cost increase in the June quarter, which keeps a downward bias on capacity until that improves.
Lennar Lennar (NYSE:LEN) saw a 43% increase in shares held. The buy ran straight into a soft quarter, exactly the kind of dislocation Berkshire historically rewards.
Lennar’s Q2 FY26 results, filed June 11, 2026, showed EPS of $1.24 (down from $1.81) on revenue of $7.94 billion (down from $8.38 billion), with gross margin on home sales compressing to 16% from 18% and average sales price down 5% to $371,000. Operationally: construction cycle time fell to a record-low 121 days from 132, construction costs improved 2% sequentially, and Lennar runs an asset-light strategy with less than 5% of land on the balance sheet. The company also repurchased 5 million shares for $447 million at an average $89.35 during Q2, near current levels.
CEO Stuart Miller framed the setup bluntly: “The fundamental shortage of housing in America has not been solved. Demand is real, deferred, and building.” The gap between current 13% incentive levels and a normalized 4% to 6% is narrowing for the first time in three years, which is the leading indicator that matters.
Shares trade at $92.72 with a $19.96 billion market cap, down 14% year to date and down 20% over one year. That weakness is precisely what Berkshire was buying.
Risk: Mortgage rates remain elevated, net homebuilding debt jumped to $1.98 billion from $643 million at the end of Q4 2025, and buyer incentives at 13% are still doing heavy lifting. Margins need that incentive number to compress.
Alphabet Alphabet (NASDAQ:GOOGL) was the most aggressive add of the quarter, with Berkshire growing the Class A position by 204% and initiating a brand-new Class C (GOOG) stake. That is a portfolio-level statement on AI infrastructure.
The Q1 FY26 numbers explain the conviction. Alphabet delivered EPS of $5.11 versus $2.63 consensus on revenue of $109.90 billion (+22%), with operating income of $39.70 billion (+30%) and a 36% operating margin. Google Cloud put up $20.03 billion in revenue (+63%) with backlog nearly doubling quarter over quarter to more than $460 billion. Consumer AI is monetizing: 350 million paid subscriptions, Gemini Enterprise paid MAU growth of 40% QoQ, and Waymo running more than 500,000 fully autonomous rides per week. Sundar Pichai’s framing: “2026 is off to a terrific start. Our AI investments and full stack approach are lighting up every part of the business.”
Valuation is the rare part. Alphabet trades at a P/E of 15 with 36% ROE and a 33% net margin. The stock at $350.12 is down 13% since the 13F filing despite being up 110% over one year. Analyst consensus is 89% bullish with a $432.83 target, and the base-case model points to $437.05 over twelve months, implying 25% upside.
Risk: CapEx is the swing factor. Q1 CapEx hit $35.67 billion (+107%), free cash flow fell 47% to $10.1 billion, and full-year CapEx guidance sits at $175 billion to $185 billion. The ROI clock on those AI build-outs is now ticking in plain view.
What to watch Three different theses, one common thread: Abel is buying earnings power where current sentiment underprices it. The next 13F, due August, will show whether these were starter positions or down payments.
New research warns of $143 billion in revenue at risk in the U.S. alone, as clients expect AI-driven value from providers Companies at risk of losing 24% of talent within two years if their firms fail to deliver on AI At the same time, one third of lawyers, accountants and compliance professionals are using unsanctioned AI, creating invisible risks organizations cannot monitor or control , /PRNewswire/ -- Thomson Reuters (Nasdaq/TSX:TRI), a global content and technology company, today released its 2026 Future of Professionals report which warns of the financial cost of failing to effectively implement AI across the legal, tax and audit and risk professions. The findings, based on a global survey of 1,800 professionals, show a widening gap between AI ambition and reality, one that is now carrying material consequences with up to $143 billion in client revenue at risk in the U.S. alone* and talent considering leaving.
"We're seeing a clear divide emerge," said Steve Hasker, President and CEO of Thomson Reuters. "Firms that are operationalizing AI are pulling ahead. Those that aren't are starting to take on real risk, across talent, clients, and financial performance. Closing that execution gap is now a business imperative for professional firms."
AI adoption is not the issue. 74% of professionals are already using AI tools every week, but organizations are struggling to translate that usage into real value. In fact, 91% of professionals believe their organizations are falling short of what AI can deliver, leading to unintended consequences such as one-third of lawyers, accountants, and compliance professionals saying they turn to unsanctioned tools, creating invisible, unmanaged risk.
Even where an AI strategy exists, execution is lagging: 35% say ambitions are not reflected in their day-to-day work, and nearly one in five say their organization still lacks a clear strategy. This gap between promise and reality is beginning to affect talent, with one in four professionals saying they would consider leaving within two years if they don't see the value they expect. Clients are reaching the same conclusion: 78% now see AI-enabled quality improvements as essential, yet just 6% believe most providers are delivering. As a result, nearly a third are preparing to reassess those provider relationships within the next 12 months.
These pressures are building faster than many leaders recognize, and are showing up in three interconnected areas:
Shadow AI is creating risk exposure
A third of lawyers, accountants and compliance professionals are using AI their organization has not approved, rising to 41% among those who say their organization is moving too slowly on AI. 96% say their AI must safeguard confidential data, 94% require verified authoritative content, and 90% need outputs they can explain and defend. Yet 41% lack access to professional-grade tools that meet these standards. Talent is leaving
One in four professionals (24%) who are experiencing a gap between what AI technology is capable of, and what their organization is delivering are considering leaving within two years; and 13% within 12 months. Yet almost half of senior leaders believe meaningful talent pressure is still at least three years away. 62% say access to professional-grade AI would be a factor in accepting a new role. Among those already using it, nearly one in three would turn a role down without it. Clients are not waiting
78% of corporate clients now consider AI-enabled quality improvements very important or essential, yet just 6% say most of their providers deliver it. Within 12 months, 32% will be reconsidering provider relationships, with a third putting more than $1 million in annual work at risk, amounting to a combined ~$143 billion in U.S. legal and accounting revenue under active reconsideration based on AI delivery. "Not all AI is created equal. In professions where there is real liability, the standard has to be much higher," said Steve Hasker, President and CEO of Thomson Reuters. "When outputs shape legal judgments, regulatory filings, or client advice, 'almost right' isn't good enough. That's why we build what we call Fiduciary‑Grade AI, technology professionals can verify, trust, and ultimately stand behind."
Read the full Future of Professionals report 2026 here.
The technology is ready. The gap is in execution, and the benchmark is now accountability. Thomson Reuters defines this as Fiduciary-Grade™ AI, built on authoritative, domain‑specific content; rigorous privacy and security; subject-matter expertise; outputs that are transparent and verifiable; and access to real-time human support.
About Thomson Reuters
Thomson Reuters (TSX/Nasdaq: TRI) informs the way forward by bringing together the trusted content and technology that people and organizations need to make the right decisions. The company serves professionals across legal, tax, accounting, compliance, government, and media. Its products combine highly specialized software and insights to empower professionals with the data, intelligence, and solutions needed to make informed decisions, and to help institutions in their pursuit of justice, truth, and transparency. Reuters, part of Thomson Reuters, is a world leading provider of trusted journalism and news. For more information, visit thomsonreuters.com.
About the Future of Professionals Report 2026
Now in its fourth year, the Thomson Reuters Future of Professionals Report is an annual study of how technology is reshaping professional work. The findings in the 2026 report are based on a global survey of 1,816 professionals across law, tax, audit, accounting, compliance, risk, and global trade, conducted in March - April 2026. Respondents span private practice firms as well as in-house corporate and government departments across 62 countries. For more information visit http://www.thomsonreuters.com/en/institute/future-of-professionals-2026/report.
Notes to Editors
* According to Future of Professionals data, within 12 months, 32% of corporate clients will be reconsidering their professional service provider relationships, with a third saying this will put more than $1 million in annual work at risk. Applied to the U.S. legal and CPA markets, this puts a combined ~$143 billion in client revenue in active reconsideration.
Media Contact
Samina Ansari, Corporate Communications
[email protected]
First-To-Market Capability Combines Premium Streaming Inventory, Audience Intelligence and Sequential Creative to Help Brands Move Beyond the One Size Fits All Ad Experience
Announcement Marks Day 3 of Omnicom Media's Cannes News Blitz Revealing First-Mover Partnerships That Connect Content to Platform Programming, Viewing Experiences and Consumer Expectations
, /PRNewswire/ -- Omnicom Media, an Omnicom (NYSE: OMC) Connected Capability, and Paramount today announced a new collaboration to enhance Paramount's Streaming Fixed Units, which delivers high-impact guaranteed placements during the first seven days of new episode premieres for Paramount's biggest series. Through this collaboration, Paramount and Omnicom will transform the ad format from a fixed creative execution into an adaptive, intelligent, and contextually responsive advertising environment – designed to create a more dynamic and personalized experience for audiences and brand marketers.
Omnicom's audience intelligence and measurement infrastructure will combine with Paramount's premium streaming inventory to adapt a brand's creative messaging based on audience, location, or other relevant information. Advertisers can also guide viewers through a progressive narrative arc, optimized for smarter storytelling with each subsequent touchpoint delivering the next chapter of a campaign. Messaging is frequency capped and sequenced to create a more intentional consumer engagement while preserving scale and enabling measurement.
The collaboration was developed in response to findings from Omnicom Media's Connected Content study, which examined consumer sentiment around the current advertising landscape and explored the factors that drive engagement across both content and delivery experiences. The research found that audiences are increasingly receptive to advertising experiences that feel relevant, intentional, and connected rather than repetitive.
"This solution is about bringing intelligence and narrative progression to one of streaming's most valuable ad formats," said Megan Pagliuca, Chief Product Officer, Omnicom Media. "Consumers have made it clear that repetitive, advertising diminishes engagement. By combining premium streaming inventory with audience intelligence and sequential storytelling, we are creating a model that allows brands to build momentum and relevance with audiences over time rather than restarting the conversation with every impression."
"Streaming has created enormous opportunities for premium storytelling, and advertisers are looking for ways to make those moments work harder," said Leo O'Conner, Executive Vice President, Digital & Streaming, Paramount Advertising. "Together with Omnicom Media, we are evolving Streaming Fixed Units into a smarter, more adaptive advertising experience that combines the impact of premiere programming with the precision and accountability marketers increasingly expect."
The capability is currently in beta tests with several Omnicom Media clients, including Volkswagen of America and Princess Cruises.
"We have been chasing relevance and creative storytelling at scale in streaming environments for years. What makes this approach compelling is the ability to turn a high-impact premiere placement into the beginning of a connected, multiple exposure consumer journey. It creates the potential for us to more intentionally and effectively engage our target audience and make each impression more purposeful." Nick Charrow, Director of Media for beta-test participant Princess Cruises
How It Works
Under the new solution, audience intelligence from Omnicom's Acxiom identity platform is integrated into Paramount's streaming environment to inform real-time creative decisioning of the Streaming Fixed Units during the seven-day premiere window. Viewers exposed to the initial ad are then entered into a retargeting pool, allowing brands to deliver sequenced creative messaging enabled- by the Omnicom Production AI-driven content and production engine - throughout the remainder of the campaign window.
The initiative also creates new opportunities for advertisers to connect the creative experience in streaming to measurable business outcomes. Through Omni Video Content, in partnership with VideoAmp, brands can connect business objectives, including downstream search and conversion activity, to Streaming Fixed Unit creative versions. Brands will also be able to extend sequential storytelling across multiple premiere events, creating larger connected narratives personalized to different audience segments.
The solution is expected to be fully live in the US for Omnicom clients in Q3, and internationally by Q1 2027
CONTACT: [email protected]
About Omnicom Media
Omnicom Media, an Omnicom (NYSE: OMC) Connected Capability, is the world's largest global media management network. Powered by the Omni Intelligence Platform, Omnicom Media agencies leverage $75.6 billion in billings, 40,000+ specialists across 70+ markets, and the industry's most powerful portfolio identity, commerce, and intelligence assets to design dynamic Growth Ecosystems that enable the world's most ambitious businesses to grow faster and smarter. The Omnicom Media portfolio includes global media agency brands OMD, Initiative, PHD, UM, Hearts & Science, and Mediahub; core Omnicom Integrated Media offerings Acxiom, the world's premier identity solution, and the Flywheel digital commerce practice; and specialty services across the cloud consulting, creator, financial, healthcare, and sports & entertainment categories. For more information visit omnicommedia.com
About Paramount, a Skydance Corporation
Paramount, a Skydance Corporation (Nasdaq: PSKY) is a leading, next‑generation global media and entertainment company, comprised of three business segments: Studios, Direct-to-Consumer, and TV Media. The Company's portfolio unites legendary brands, including Paramount Pictures, Paramount Television, CBS, CBS News, CBS Sports, Nickelodeon, MTV, BET, Comedy Central, SHOWTIME®, Paramount+, Pluto TV, Skydance Animation, Film, Television, and Interactive/Games, and the newly established Paramount Sports Entertainment. For more information, please visit www.paramount.com.
The now mid-cap semiconductor industry stock Aehr Test Systems NASDAQ: AEHR has continued to trudge higher and higher in 2026. On the year, shares of this semiconductor testing equipment company are up more than 400%. This has allowed the company’s market capitalization to soar from around $600 million at the beginning of 2026 to around $3.5 billion.
Aehr Test Systems Today
AEHR
Aehr Test Systems
$96.80 -5.59 (-5.46%)
As of 12:08 PM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range$11.61▼
$126.62Price Target$68.00
The company’s frequent order announcements have been crucial to the stock’s rise, while general semiconductor strength has also helped. Notably, Aehr just received its latest boost from the combination of these two factors, adding more fuel to the fire after two months without announcing new orders.
Get Aehr Test Systems alerts:
Despite these positive business developments, Aehr’s current financials show a drastic divergence from its valuation. With this, the question going forward is whether this stock has gotten ahead of its skis.
Aehr Announces Follow-On Order From Optical CustomerIn mid-April, Aehr said it had received a record $41 million follow-on production order from its lead hyperscale customer. This order related to the company’s package-level burn-in Sonoma systems. In semiconductor manufacturing, many chips are built on one large wafer. They are then individually cut from that wafer and placed into protective packaging. This is the stage at which Sonoma tests chips.
After being relatively silent on orders for two months, the company made its newest announcement in mid-June. According to Aehr, the company “received a follow-on production order for a fully automated FOX-XP wafer-level burn-in system.”
FOX-XP performs tests at the earlier wafer level stage, putting the entire wafer under stressful conditions to check for flaws. This distinction is important to understand because orders of both Sonoma and FOX-XP show that Aehr is finding customers at multiple stages of the manufacturing process.
Aehr added that this FOX-XP order came from a “global leader in networking products and solutions and a major supplier to the data center optical transceiver market.” This is interesting because optical transceivers are seeing a surge in demand.
Optical transceivers enable high-speed data transfer over long distances, which is increasingly important as data centers expand and process more information. Recent estimates say that optical transceiver sales rose by 70% year-over-year to $18 billion. By gaining customers here, Aehr could benefit from the high growth rates in this space.
Aehr: Small New Order, High ValuationDespite these positives, it is worth noting that the order is not large by any means. It is only for one FOX-XP system, or essentially the smallest order the firm could have announced. However, Aehr also said the customer provided a “forecast for additional systems this calendar year as it ramps capacity to support next generation hyperscale data center deployments.”
Another positive was Aehr noting that over 25 total customers have deployed FOX-XP thus far. This indicates a solid level of diversification among its customer base, although the actual breakdown in sales between them is unknown. On the day of this news, Aehr's stock rose by about 7%. Semiconductor strength also added to the rally, with the iShares Semiconductor ETF NASDAQ: SOXX rising about 1.4%.
Aehr Test Systems (AEHR) Price Chart for Wednesday, June, 24, 2026
As noted, Aehr has now surged to a market capitalization near $3.5 billion. Meanwhile, the company generated just $10.3 million in revenue last quarter. Over the next 12 months, analysts expect the firm to generate around $82 million in revenue. This implies a forward price-to-sales (P/S) ratio of around 43x. That figure is more than four times higher than its average forward P/S ratio of 10x over the past three years. Additionally, over the next 12 months, analysts expect Aehr to generate negative operating income.
This comes as, despite the company announcing many orders, its sales and profitability metrics have yet to improve. Notably, revenue dropped 44% year over year (YOY) in its latest quarter. Meanwhile, its adjusted earnings per share dropped from 7 cents to -5 cents. On the other hand, its backlog hit a record $50.9 million, which came prior to its record $41 million follow-on order in April. While Aehr’s financials are being strained today, these figures point to significant improvements going forward.
Aehr: Investors Wait for Financials to Catch Up to ValuationAehr’s valuation creates real room for concern. Still, the company is undeniably generating strong interest for its products, and it is fully possible that more order announcements are on the way. These factors reiterate the high-risk-high-reward setup for Aehr stock.
Ultimately, seeing orders translate into actual sales and earnings improvements will be key going forward. The company will have another opportunity to demonstrate this in its next earnings report, which, based on its past releases, should take place in July.
Should You Invest $1,000 in Aehr Test Systems Right Now?Before you consider Aehr Test Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aehr Test Systems wasn't on the list.
While Aehr Test Systems currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Key Takeaways Lincoln National is benefiting from growth in spread-based annuities and stronger Life Insurance sales.LNC's annuity sales rose 4% YoY to $3.9B, with spread-based products making up nearly two-thirds.LNC expects its RBC ratio to stay above 420%, supporting growth while maintaining strength. Lincoln National Corporation (LNC - Free Report) is strategically positioned for growth, supported by its ongoing business transformation, driven by growth in spread-based annuity products, improving momentum in Life Insurance and Group Protection, disciplined expense management and a strengthened capital position that supports sustainable earnings growth.
With a market capitalization of $7.2 billion, Lincoln National is a diversified life insurance and investment management company that provides a wide range of wealth accumulation, wealth protection, group protection and retirement products and solutions. The company operates multiple insurance businesses through four business segments: Annuities, Life Insurance, Group Protection and Retirement Plan Services. LNC stock has risen 13.7% over the past year compared with the industry’s average gain of 16.4%.
Courtesy of solid prospects, LNC currently carries a Zacks Rank #3 (Hold).
Where Do Estimates for LNC Stand?The Zacks Consensus Estimate for Lincoln National’s 2026 earnings is pegged at $7.72 per share. In the past 30 days, it has witnessed two upward estimate revisions against one in the opposite direction. Furthermore, the consensus mark for revenues is pegged at $19.5 billion for 2026, indicating a 2.2% year-over-year rise. It beat earnings estimates in each of the past four quarters, with an average surprise of 13.8%.
LNC Stock’s Growth DriversLincoln National continues to benefit from the transformation of its annuity franchise toward products that generate steadier earnings and require less capital. The company has been emphasizing spread-based offerings such as fixed indexed annuities and RILAs while reducing exposure to more market-sensitive business. This shift is helping improve the quality of earnings and supporting long-term cash flow generation. In the first quarter of 2026, annuity sales rose 4% year over year to $3.9 billion, with spread-based products accounting for nearly two-thirds of total sales.
The Life Insurance segment is emerging as another key growth driver. LNC has repositioned the business toward accumulation-focused products, executive benefits solutions and offerings with more predictable profitability characteristics. These product lines are expected to support sales growth while enhancing profitability and capital efficiency. Total life insurance sales climbed 33% year over year to $129 million in the first quarter of 2026.
LNC continues to expand its Group Protection franchise through targeted market strategies, supplemental health offerings and enhanced digital tools for employers and brokers. These efforts helped drive a 10.9% increase in operating income to $112 million in the first quarter of 2026.
Lincoln National is also investing heavily in technology modernization and operational efficiency initiatives across its businesses. The company is expanding digital capabilities, automating processes and enhancing self-service tools to improve customer and distributor experiences while creating operating leverage. These initiatives are supporting growth in Retirement Plan Services.
In addition, LNC remains focused on disciplined capital management, free cash flow generation and balance sheet strength. As of March 31, 2026, holding company available liquidity rose to $805 million (net of prefunding) from $655 million at the 2025-end. Lincoln National expects its RBC ratio to remain above the 420% target, reflecting solid capitalization to fund growth initiatives while maintaining financial strength.
Key ConcernLincoln National has relatively higher financial leverage compared to the industry, with a total debt-to-capital of around 38.4%, significantly above the industry average of 15.2%. This elevated leverage may increase financial risk, particularly amid volatile market conditions.
LNC is currently trading at 0.78X trailing 12-month price-to-book, below its three-year median of 0.79X and the industry average of 2.17X, reflecting lingering investor skepticism.
Key PicksSome better-ranked stocks in the broader finance space are Alerus Financial Corporation (ALRS - Free Report) , Pelagos Insurance Capital Ltd. (PLGO - Free Report) and Cboe Global Markets, Inc. (CBOE - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Alerus Financial’s current-year earnings of $2.95 per share has witnessed two upward revisions in the past 60 days against none in the opposite direction. ALRS’ earnings beat estimates in each of the trailing four quarters, with the average surprise being 35.8%. The consensus estimate for current-year revenues is pegged at $306.2 million, suggesting a 3.8% year-over-year jump.
The consensus estimate for Pelagos Insurance Capital’s current-year earnings is pegged at $3.78 per share, which signals 96.9% year-over-year growth. Its earnings beat estimates in three of the trailing four quarters and missed once, with the average surprise being 53.6%. The consensus mark for PLGO’s current-year revenues of $2.8 billion implies 11.4% year-over-year growth.
The consensus estimate for Cboe Global Markets’ current-year earnings is pegged at $13.34 per share, which has witnessed two upward revisions in the past 30 days against none in the opposite direction. Its earnings beat estimates in each of the trailing four quarters, with the average surprise being 5.4%. The consensus estimate for CBOE’s current-year revenues is pegged at $2.8 billion, which implies a 13.1% year-over-year rise.
Build and Maintain Skills Automatically From Real-Time and Historical Data, Then Connect Customers to the Best Expert Across Channels and the Entire Organization
CAMPBELL, Calif.--(BUSINESS WIRE)--Most interaction routing systems don't actually route. They queue. Agents are assigned based on skills entered manually, updated rarely, and calibrated to who's available, not who's actually best suited to help a specific customer in a specific moment. When the right expert sits outside the contact center, in billing, customer success, or a technical team, the customer gets bounced, transferred again, or lost entirely.
8x8, Inc. (NASDAQ: EGHT), a leading global business communications platform provider, is setting a new standard with the introduction of 8x8 AI Routing, an organization-wide intelligent routing engine that dynamically matches every customer to the best available resource, regardless of where they sit, in real time.
Unlike legacy, often rigid, skills-based routing systems that have been the industry standard for decades, 8x8 AI Routing functions as a platform-level service. Designed to identify the right resource for each interaction, whether that's a contact center agent on 8x8 Contact Center, a subject matter expert on 8x8 Engage, or a back-office employee on 8x8 Work, 8x8 AI Routing delivers across any channel, at scale, through a single customer interaction routing layer.
“AI-powered routing has long promised a lot, but vendors have largely failed to address one key challenge: automatically assigning and maintaining agent skills and proficiency levels. Using interaction transcripts, previous history, sentiment and other real-time factors, 8x8 AI Routing analyzes data, suggests skills and skill levels for each agent, and lets administrators accept or adjust those assignments. The routing engine reanalyzes the data to recommend additional skill or level changes based on the agent’s actual work, again for admin review,” said Sheila McGee-Smith, founder and principal analyst at McGee-Smith Analytics. “What is even more powerful is that 8x8 can evaluate each inbound interaction and determine who — across the entire enterprise, not just the contact center — is best equipped to resolve the customer’s intent.”
Every decision, explained
Every interaction is evaluated across several real-time factors and matched to the right resource instantly. When the best match isn't immediately available, the system adjusts automatically, keeping customers moving forward without transfers, delays, or dead ends.
8x8 AI Routing puts supervisors in control from day one. Teams can pilot on a single queue before full rollout, expanding at their own pace and shaping how the system works as confidence grows. All decisions are on the record: supervisors can pull exportable audit trails showing exactly why each interaction went to each resource, including confidence scores and complete rationale across all factors.
One-click setup
Most interaction routing deployments take months to configure and require ongoing maintenance just to stay accurate as the business evolves. 8x8 AI Routing eliminates that burden. By analyzing rich interaction data, including transcripts, sentiment, and historical patterns, AI builds and suggests skill configurations automatically, manages automated skill profiles as teams and needs change, detects customer intent without manual interactive voice response (IVR) mapping, and gets teams delivering value from day one, not months from now.
Connects to existing infrastructure, adapts as the business evolves
8x8 AI Routing connects to 8x8 Intelligent Customer Assistant, 8x8 AI Studio, IVRs, and third-party bots, routing interactions from any entry point to the right person at the right moment, however the stack is built today. As new channels, tools, and teams are added, the routing layer grows with them.
"The routing problem has always been about architecture,” said Hunter Middleton, Chief Product Officer at 8x8. “The best person for a given customer interaction might sit anywhere in the business, but most systems were never designed to look beyond their own boundaries. 8x8 AI Routing was built differently, spanning all teams and boundaries in the business simultaneously and evaluating the full range of available resources in real time. That's a challenge point solutions fundamentally struggle to solve, and exactly the kind a true platform is built for."
8x8 AI Routing is available now for select 8x8 customers, who can contact their 8x8 Account Manager or Customer Success Manager to get started. 8x8 AI Routing will be on display at 8x8’s booth, #601, during Customer Contact Week (CCW) in Las Vegas, June 22-25.
About 8x8, Inc.
8x8, Inc. (NASDAQ: EGHT) connects people and organizations through seamless communication on one of the industry's most integrated platforms for Customer Experience – combining Contact Center, Unified Communications, and CPaaS solutions. The 8x8® Platform for CX integrates AI to enable personalized customer journeys, drive operational excellence and insights, and facilitate team collaboration. As a business communications leader, the company helps customer experience and IT leaders around the world become the heartbeat of their organizations, empowering them to unlock the potential of every interaction. For additional information, visit www.8x8.com, or follow 8x8 on LinkedIn, X, and Facebook.
Caution Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding the expected capabilities and availability of the 8x8 AI Routing. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially. For a discussion of these risks and uncertainties, please refer to 8x8's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. 8x8 assumes no obligation to update any forward-looking statements to reflect events that occur or circumstances that exist after the date on which they were made.
Copyright 2026 8x8, Inc. 8x8 and associated brand assets are trademarks of 8x8, Inc. All rights reserved.
Most interaction routing systems don't actually route. They queue. Agents are assigned based on skills entered manually, updated rarely, and calibrated to who's available, not who's actually best suited to help a specific customer in a specific moment. When the right expert sits outside the contact center, in billing, customer success, or a technical team, the customer gets bounced, transferred again, or lost entirely.
8x8, Inc. (NASDAQ: EGHT), a leading global business communications platform provider, is setting a new standard with the introduction of 8x8 AI Routing, an organization-wide intelligent routing engine that dynamically matches every customer to the best available resource, regardless of where they sit, in real time.
Unlike legacy, often rigid, skills-based routing systems that have been the industry standard for decades, 8x8 AI Routing functions as a platform-level service. Designed to identify the right resource for each interaction, whether that's a contact center agent on 8x8 Contact Center, a subject matter expert on 8x8 Engage, or a back-office employee on 8x8 Work, 8x8 AI Routing delivers across any channel, at scale, through a single customer interaction routing layer.
“AI-powered routing has long promised a lot, but vendors have largely failed to address one key challenge: automatically assigning and maintaining agent skills and proficiency levels. Using interaction transcripts, previous history, sentiment and other real-time factors, 8x8 AI Routing analyzes data, suggests skills and skill levels for each agent, and lets administrators accept or adjust those assignments. The routing engine reanalyzes the data to recommend additional skill or level changes based on the agent’s actual work, again for admin review,” said Sheila McGee-Smith, founder and principal analyst at McGee-Smith Analytics. “What is even more powerful is that 8x8 can evaluate each inbound interaction and determine who — across the entire enterprise, not just the contact center — is best equipped to resolve the customer’s intent.”
Every decision, explained
Every interaction is evaluated across several real-time factors and matched to the right resource instantly. When the best match isn't immediately available, the system adjusts automatically, keeping customers moving forward without transfers, delays, or dead ends.
8x8 AI Routing puts supervisors in control from day one. Teams can pilot on a single queue before full rollout, expanding at their own pace and shaping how the system works as confidence grows. All decisions are on the record: supervisors can pull exportable audit trails showing exactly why each interaction went to each resource, including confidence scores and complete rationale across all factors.
One-click setup
Most interaction routing deployments take months to configure and require ongoing maintenance just to stay accurate as the business evolves. 8x8 AI Routing eliminates that burden. By analyzing rich interaction data, including transcripts, sentiment, and historical patterns, AI builds and suggests skill configurations automatically, manages automated skill profiles as teams and needs change, detects customer intent without manual interactive voice response (IVR) mapping, and gets teams delivering value from day one, not months from now.
Connects to existing infrastructure, adapts as the business evolves
8x8 AI Routing connects to 8x8 Intelligent Customer Assistant, 8x8 AI Studio, IVRs, and third-party bots, routing interactions from any entry point to the right person at the right moment, however the stack is built today. As new channels, tools, and teams are added, the routing layer grows with them.
"The routing problem has always been about architecture,” said Hunter Middleton, Chief Product Officer at 8x8. “The best person for a given customer interaction might sit anywhere in the business, but most systems were never designed to look beyond their own boundaries. 8x8 AI Routing was built differently, spanning all teams and boundaries in the business simultaneously and evaluating the full range of available resources in real time. That's a challenge point solutions fundamentally struggle to solve, and exactly the kind a true platform is built for."
8x8 AI Routing is available now for select 8x8 customers, who can contact their 8x8 Account Manager or Customer Success Manager to get started. 8x8 AI Routing will be on display at 8x8’s booth, #601, during Customer Contact Week (CCW) in Las Vegas, June 22-25.
About 8x8, Inc.
8x8, Inc. (NASDAQ: EGHT) connects people and organizations through seamless communication on one of the industry's most integrated platforms for Customer Experience – combining Contact Center, Unified Communications, and CPaaS solutions. The 8x8® Platform for CX integrates AI to enable personalized customer journeys, drive operational excellence and insights, and facilitate team collaboration. As a business communications leader, the company helps customer experience and IT leaders around the world become the heartbeat of their organizations, empowering them to unlock the potential of every interaction. For additional information, visit www.8x8.com, or follow 8x8 on LinkedIn, X, and Facebook.
Caution Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding the expected capabilities and availability of the 8x8 AI Routing. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially. For a discussion of these risks and uncertainties, please refer to 8x8's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. 8x8 assumes no obligation to update any forward-looking statements to reflect events that occur or circumstances that exist after the date on which they were made.
Copyright 2026 8x8, Inc. 8x8 and associated brand assets are trademarks of 8x8, Inc. All rights reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260624289569/en/
Analyst’s Disclosure: I/we have a beneficial long position in the shares of VICI either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
EWING, N.J.--(BUSINESS WIRE)--Universal Display Corporation (UDC) (Nasdaq: OLED), a global leader in energy-efficient OLED technologies and materials, congratulates Professor Stephen R. Forrest, Peter A. Franken Distinguished University Professor of Engineering at the University of Michigan and a member of UDC’s Scientific Advisory Board, on his election as a Fellow of the Royal Society, the United Kingdom’s national academy of sciences.
Prof. Forrest is among 90 leading researchers newly elected to the Royal Society. According to the organization, Fellows are selected based on scientific excellence and their substantial contributions to the advancement of natural knowledge.
“We are delighted to congratulate Steve on this remarkable and well-deserved recognition,” said Steven V. Abramson, President and Chief Executive Officer of Universal Display Corporation. “Prof. Forrest’s pioneering work in organic electronics and optoelectronics helped lay the scientific groundwork for UDC and the broader OLED industry. Today, UDC has grown into a leader in the OLED ecosystem, with teams of scientists and engineers advancing new levels of power efficiency and performance for displays around the world. As we carry this important work forward, we continue to value Steve’s strong partnership and his ongoing contributions to scientific research.”
About Universal Display Corporation
Universal Display Corporation (Nasdaq: OLED) is a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. Founded in 1994 and with subsidiaries and offices around the world, the Company currently owns, exclusively licenses or has the sole right to sublicense more than 7,000 patents issued and pending worldwide. Universal Display licenses its proprietary technologies, including its breakthrough high-efficiency UniversalPHOLED® phosphorescent OLED technology that can enable the development of energy-efficient and eco-friendly displays and solid-state lighting. The Company also develops and offers high-quality, state-of-the-art UniversalPHOLED materials that are recognized as key ingredients in the fabrication of OLEDs with peak performance. In addition, Universal Display delivers innovative and customized solutions to its clients and partners through technology transfer, collaborative technology development and on-site training. To learn more about Universal Display Corporation, please visit https://oled.com/.
Universal Display Corporation and the Universal Display Corporation logo are trademarks or registered trademarks of Universal Display Corporation. All other Company, brand or product names may be trademarks or registered trademarks.
All statements in this document that are not historical, such as those relating to the projected adoption, development and advancement of the Company’s technologies, and the Company’s expected results, as well as the growth of the OLED market and the Company’s opportunities in that market, are forward-looking financial statements within the meaning of the Private Securities Litigation Reform Act of 1995. You are cautioned not to place undue reliance on any forward-looking statements in this document, as they reflect Universal Display Corporation’s current views with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated. These risks and uncertainties are discussed in greater detail in Universal Display Corporation’s periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission, including, in particular, the section entitled “Risk Factors” in Universal Display Corporation’s Annual Report on Form 10-K for the year ended December 31, 2025. Universal Display Corporation disclaims any obligation to update any forward-looking statement contained in this document.
Kopin Expands U.S. Operations With New Optics & Photonics Design Center in Dallas, Texas Kopin Corporation (NASDAQ: KOPN) a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced plans to open a new Optics and Photonics Design Center in Dallas, Texas, further expanding the company’s U.S.‑based engineering footprint and accelerating development of next‑generation Neural I/o™ technology for the rapidly growing AI infrastructure market.
Scheduled to open before the end of 2026, the Dallas facility will serve as a hub for advanced research, design engineering, and small‑scale manufacturing. The center will include:
New optics and photonics lab space A dedicated design and engineering center Advanced R&D capabilities focused on Neural I/o™ Manufacturing capacity for Neural I/o™ and ASOS systems Expertise across optomechanical, hardware, and software deployment disciplines Located in Dallas — one of the nation’s leading hubs for optical data communication — the new site positions Kopin at the center of a growing ecosystem of high‑performance computing, data transport, and photonics innovation.
Kopin CEO Michael Murray said: “Our expansion into Dallas marks a pivotal step in Kopin’s evolution. Establishing a dedicated Optics and Photonics Design Center in one of the country’s leading hotspots for optical data infrastructure strengthens our domestic engineering capabilities and accelerates our ability to deliver next‑generation Neural I/o™ systems. This new facility enhances our capacity, deepens our expertise, and positions us to rapidly support customer programs across the AI infrastructure landscape. The Dallas center will allow us to rapidly deploy Neural I/o™ and ASOS systems while scaling the design resources needed to meet accelerating demand. It’s a major investment in the future of U.S.‑based innovation — and a testament to the incredible momentum our team is building.”
Josh Silverman, Chief Executive Officer of Fabric.AI, added: "Kopin's investment in a dedicated Dallas design center is exactly the kind of commitment that turns a breakthrough interconnect into a deployable product. The work we're doing together on Neural I/o™ is aimed squarely at the bandwidth and power bottlenecks that define the AI infrastructure buildout, and having advanced optics R&D and manufacturing under one U.S.-based roof lets us move from design to customer deployment far faster. This expansion accelerates our shared roadmap at precisely the moment the market needs it."
The new facility marks another major step in Kopin’s strategy to expand U.S.‑based operations, enhance domestic supply chain resilience, and advance the company’s leadership in next‑generation optical and photonic technologies.
About Kopin
Kopin Corporation (Nasdaq: KOPN) is a leading developer and provider of innovative display, Optical Interconnect devices and application-specific optical solutions sold as critical components and subassemblies for defense, enterprise, professional and consumer products. Kopin’s portfolio includes microdisplays, display modules, eyepiece assemblies, image projection modules and vehicle mounted and head-mounted display systems that incorporate ultra-small high-resolution Active Matrix Liquid Crystal displays (AMLCD), Ferroelectric Liquid Crystal on Silicon (FLCoS) displays, MicroLED displays (µLED) and Organic Light Emitting Diode (OLED) displays, a variety of optics and low-power ASICs and optical interconnect devices for data centers.
For more information, please visit Kopin’s website at www.kopin.com.
Kopin is a trademark of Kopin Corporation.
Follow us on LinkedIn, X and Facebook.
Forward Looking Statements
Statements in this press release may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the safe harbor created by such sections. Words such as “expects,” “believes,” “can,” “will,” “estimates,” and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. We caution readers not to place undue reliance on any such “forward-looking statements,” which speak only as of the date made, and advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. These forward-looking statements may include statements with respect to our belief that the landmark award accelerates Kopin’s development of ultra-bright, full-color MicroLED displays optimized for ground soldier augmented reality (AR) applications, positioning the company as a cornerstone of America’s defense innovation and domestic manufacturing ecosystem; our belief that by advancing daytime and nighttime readable AR display technology, Kopin is poised to redefine battlefield vision systems, enhancing soldier lethality, situational awareness, and operational effectiveness; our belief that this award solidifies Kopin’s leadership in MicroLED technology and establishing a robust U.S.-based production capability for this critical defense technology; our belief that this award positions Kopin to win future defense programs that rely on full-color MicroLED for next-generation AR systems; our belief that our initiatives create a powerful synergy, positioning Kopin at the forefront of soldier-centric AR innovation; our belief that this award positions Kopin as a frontrunner for future U.S. defense contracts that prioritize advanced AR solutions for enhanced soldier performance; and our belief that this is a transformative moment in Kopin’s history and growth trajectory as this contract and our expectation of follow-on non-dilutive infrastructure investment contracts will be the bedrock which we build the next decade of foundational innovations upon. Various factors, some of which are beyond our control, could cause actual results to differ materially from those expressed in, or implied by, such forward-looking statements, including without limitation our ability to produce thermal weapons displays in adequate quantities to meet projected demand, the outcome of any litigation and other factors beyond our control. All such forward-looking statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by these cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as may otherwise be required by the federal securities laws. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations are described in Part I, Item 1A. Risk Factors; Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; and other parts of our Annual Report on Form 10-K, as amended, for the fiscal year ended December 28, 2024, or as updated from time to time our Securities and Exchange Commission filings.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260623595042/en/
Manchester United Plc (NYSE:MANU)'s acquisition of land for its planned new 100,000-seat stadium represents a significant de-risking milestone for the project, removing what Jefferies described as the main outstanding hurdle around land assembly and improving visibility on the club’s long-term redevelopment plans.
The club said it has secured the majority of land required for the proposed stadium adjacent to Old Trafford through the purchase of a 25-acre site from Indurent, a Blackstone-owned industrial property company.
The site is located about 350 meters northwest of the current ground and forms part of a wider 370-acre regeneration scheme being developed alongside Trafford Council and the Old Trafford Regeneration Mayoral Development Corporation (OTRMDC).
The broader development is expected to include approximately 15,000 new homes, around 48,000 jobs, and more than £7 billion in annual economic impact for the UK economy. Further details on the project, including consultation timing and an updated masterplan, are expected from the OTRMDC on July 9.
Jefferies believes that the land deal removes a key overhang previously identified in the project and clears the path toward design finalization, cost estimation and a more defined construction timeline.
The firm also pointed to continued operational momentum under the INEOS-led transformation, alongside improving financial performance and recent commercial activity.
Manchester United recently reported stronger third-quarter results, raised its fiscal 2026 guidance, and secured qualification for the 2026–27 UEFA Champions League season. The club has also added several commercial partnerships in recent months, including deals with Snapdragon, Coca-Cola, Sokin, Parimatch and Elevate Hospitality, and completed a $550 million refinancing to extend debt maturities.
The proposed stadium would increase capacity to 100,000 seats from roughly 74,000 at Old Trafford, expanding matchday and premium hospitality potential, Jefferies highlighted.
However, it noted that key uncertainties remain around funding structure, total project cost and construction timeline as planning progresses.
Manchester United’s US-listed shares traded down 1.5% at about $22 on Monday afternoon, up about 38% so far this year.
